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ABSTRACT 
 
Brucellosis is one of the neglected diseases in Nigeria. In Lagos, the commercial capital 
of Nigeria with about twenty one million people, a descriptive cross-sectional study was 
carried out in order to determine the sero-prevalence of brucellosis among people at risk 
in some selected abattoirs and secondary health care facilities (hospitals) in the state. 
Mixed sampling method was employed at the abattoir while convenient sampling 
method was used in sampling the respondents at the hospitals. Sera samples from three 
hundred and one (n=301) abattoir-based workers and traders; and one hundred and 
twenty one (n=121) hospital-based individuals which include people with febrile illnesses 
and blood donors were tested for brucellosis using Rose Bengal Plate test (RBPT), with 
indirect ELISA being used as a confirmatory test. Of the 301 abattoir-based workers and 
traders, 27 (8.97%) were sero-positive to the infection when Rose Bengal Plate test 
antigen was used. The twenty seven individuals consists of fifteen (15) butchers; four (4) 
veterinarians; two (2) meat transporters and bone/cow horn dealers each as well as one 
each of blood meal producer, abattoir engineer, water seller and meat supplier.  When 
blood samples from the sero-positive individuals were subjected to ELISA, 3 (11.1%) 
were sero-positive to the brucellosis, while one is equivocal. These results confirm that 
agglutination observed on RBPT might be related to unknown cross-reactions and 
confirmation with a different test was necessary.  None of the hospital-based 
respondents is sero-positive to the infection. The clinical signs significant for the 
infection in this study were fever, joint pain, lower backache, regular headache and 
miscarriage. Brucellosis awareness level among the respondents was very low. Data 
was analysed using (SPSS) version 20.0 at α0.05 significant level. The significant risk 
factors for human brucellosis according to this research are consumption of fura 
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(unpasteurized milk) and wara (fresh cheese).  The study revealed that brucellosis is not 
only an occupational disease but can also affect people who trade or live in proximity 
with infected animals. 
Key words: Brucellosis, RBPT, ELISA, B. abortus, B. canis, B. melitensis, B. suis, 
people at risk 
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CHAPTER 1 
GENERAL INTRODUCTION AND LITERATURE REVIEW 
 
1.1 GENERAL INTRODUCTION 
A Gram-negative bacteria belonging to the genus Brucella cause brucellosis. Brucella 
organisms are small (0.5 to 0.7 by 0.6 to 1.5 µm), non-encapsulated, flagellated, 
facultatively intracellular coccobacilli (Centre for Food Security & Public Health, 2009; 
Wang, 2016).  The genus Brucella belongs to the family Brucellaceae within the order of 
Rhizobiales, in the class of Alphaproteobacteria and phylum of Proteobacteria (Liu, 
2015). Other genera of Alphaproteobacteria affecting mammals are Bartonella, 
Rickettsia and Ehrlichia (Fitch, 2010).  Phylogenetic studies showed that years back 
prior to domestication of livestock, Brucella species had a common ancestor B. ovis 
(Foster et al., 2009; Rossetti et al., 2017).   
 
Brucella genus comprises several species: Brucella abortus, Brucella melitensis, 
Brucella canis, Brucella suis, Brucella ovis, Brucella neotomae, Brucella ceti, Brucella 
microti and Brucella inopinata (Jimenez de Bagues et al., 2014).  The division of the 
genus into six classical species (B. melitensis, B. abortus, B. suis, B. canis, B. ovis and 
B. neotomae) is still widely used based on historical and clinical reasons (Osterman and 
Moriyon, 2006).  Though Brucella species are genetically similar, they have different 
host preferences (Table 1)  
 
1.2 HISTORY OF BRUCELLOSIS 
Hippocrates (Nielsen & Yu, 2010) first described brucellosis in the Mediterranean in 450 
BC. The presence of the disease was also confirmed by the microscopic observation of 
coccoid microorganisms similar to Brucella species in carbonized cheese (Capasso 
2002; Nielsen & Yu, 2010).  A study reported on lytic lesions of the lumbar vertebrae in 
"southern ape of Africa" (Australopithecus africanus) suggestive of brucellosis. The 
suspected source of infection could be the consumption of infected tissues from wild 
animals (D'Anastasio et al., 2009; Rossetti et al., 2017).   
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Human brucellosis is fatal in 1 to 2% of cases. Reports of 72 cases deaths were 
recorded in the British literature, although in only few of the cases pathological findings 
were described (Hunt and Bothwell, 1967).  Marston suffered from a disease that he 
described as being different from typhoid fever (Vassalo, 1992). Brucellosis, called 
―Mediterranean fever‖ was a debilitating chronic sickness with rheumatism complication 
that affected many Royal Naval seaman and sailors aboard ships each year (Wyatt, 
1999).  In 1887, Australian-born British physician, Dr. David Bruce, diagnosed 
brucellosis, named Malta fever at the time, (Rossetti et al., 2017).  Ten years later, 
Benhard Bang, a Danish Veterinarian isolated Brucella abortus while Sir Themistocles 
Zammit identified unpasteurized milk as the major source of infection for the disease.  
Overtime, brucellosis has been referred by various names which included Bang fever, 
Undulating fever, Malta fever, Mediterranean fever, Rock fever, Gibraltar fever, Cyprus 
fever, Crimean fever, Milk sickness, Goat fever, Satan‘s fever, Febris melitensis, Febris 
undulans, Melitensis septicaemia, Jones disease, Brucelliasis, Scottish Delight, 
Chumble fever and Bruce‘s septicaemia.  
 
In some parts of Africa, brucellosis is called ―Ugonjwa ya maziwa‖ meaning the disease 
from milk in Kiswahili, one of the local African languages (Lifecore Ltd, 2014).  
Worldwide, the last decade has been faced with challenges that include human 
population growth and environmental changes that have resulted in increased number 
of people living in close contact with wild and domestic animals.  Re-emergence of 
diseases has been observed and the status of a number of conditions has now become 
questionable.  Metabolic and infectious diseases such as diabetes, HIV and 
tuberculosis are widely distributed.  Any effective recommendation and intervention 
should be multidisciplinary for solutions to current situation.  
  
1.3 DIAGNOSIS OF HUMAN BRUCELLOSIS 
Clinical signs alone are not sufficient for brucellosis diagnosis. Hence, a sensitive, 
specific, rapid and inexpensive method is required. Early and appropriate diagnosis of 
this disease is effective in improving public health as well as disease control and 
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eradication (Molavi et al., 2014).  Diagnosis of human brucellosis can be by culture, 
serological test, biochemical and molecular identification. 
 
1.3.1  Diagnosis of brucellosis by culture 
The gold standard for the diagnosis of brucellosis is blood culture. Blood is the most 
frequently used materials in Brucella culture, though the pathogen can be isolated from 
cerebrospinal fluids, pus, wounds, bone marrow (which gives the highest isolation rate) 
among others. For the microbiological growth media, serum dextrose broth with 
corresponding solid phase is recommended. It must be noted however, that Brucella 
grows on most high quality peptone based media used for blood culture. Incubation 
should be conducted in air supplemented with 5% Carbon dioxide (Poester et al., 2010; 
Baddour, 2012). The automated lysis centrifugation method is used for the isolation of 
the pathogens from clinical samples (Baddour, 2012) because of increased sensitivity 
and reduced time of culture (Durmaz et al., 2003 and Baddour, 2012). This automated 
culture system replaced the traditional biphasic Ruiz-Castañeda system used for 
Brucella spp isolation from clinical samples (Ruiz-Castañeda, 1954; Ganado & 
Bannister, 1960; Yagupsky, 1999 and Baddour, 2012). The number of bacteria found in 
clinical samples may vary widely, as the isolation of Brucella is highly dependent on the 
infection stage (acute versus chronic), antibiotic pre-treatment, the existence of an 
appropriate clinical specimen and the culturing methods used (Al Dahouk, et al., 2003). 
 
BACTEC 9204 and BacT/Alert are the newer automated blood culture systems used in 
the isolation of Brucella organisms. These methods shorten the time taken for the 
detection of the pathogens considerably, with Brucella being detected by the third day of 
incubation. The preceding culture system, BACTEC NR 730 could not detect 
appreciable number of samples, which were positive by conventional blood culture 
systems. The conventional Castaneda blood culture hardly gives positive result by the 
fourth day of incubation. Majority of the positives are identified between seven to twenty 
one days of incubation; with about 2% being positive by the twenty seventh day. For this 
reason, incubation of blood culture should be carried out for about forty five days before 
it is discarded as being negative for Brucella (Baddour, 2012). It must be noted that 
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isolation rates are much higher during the initial two weeks of symptomatic disease and 
in blood cultures taken during the pyrexial phase (Al-Dahouk, 2013) 
 
Colonial morphology, Stamps or modified Ziehl Neelsen staining, slide agglutination 
with anti-brucella serum (smooth or rough), urease, catalase and oxidase tests are the 
basis for a culture to be identified as belonging to the genus Brucella. 
 
1.3.1.1  Identification and typing of Brucella organisms after Culture 
At incubation temperature of 37°C for 48-72 hours, Poester et al. (2010) reported 
growth of Brucella colonies of convex and circular outline, 0.5 to 1.0 mm in diameter. 
The smooth Brucella strains are transparent, yellow, with a semblance of honey 
droplets, and shiny surface when observed in transmitted light. The rough colonies are 
opaque with a granular surface. Dissociation of Brucella can be detected by the 
emulsification of a colony in 0.1% w/v aqueous acriflavine. The smooth colonies 
produce a uniform yellow suspension while the rough strains are seen as granular 
agglutinates.  
 
Once Brucella is identified after culturing, species and biovar classification is important. 
This should be done in reference or specialized laboratories. These tests are 
cumbersome and include carbon dioxide requirement, production of hydrogen sulphide 
(H2S), dye sensitivity (thionin and basic fuchsin), phage lysis, agglutination with A, M or 
R specific antisera; and in some cases, it is necessary to use the oxidative metabolic 
method.  For example, Corbel (1984) reported that the three principal Brucella species- 
Brucella melitensis, Brucella abortus and Brucella suis have been differentiated largely 
based on their requirement for supplementary carbon dioxide on primary isolation, the 
production of hydrogen sulphide, ability to grow in the presence of selected dyes, and 
their reaction in agglutination tests with absorbed antisera. This latter test is time 
consuming and hazardous to laboratory personnel.  
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1.3.1.2 Molecular diagnosis of human brucellosis 
This method of diagnosis in humans involves the use of polymerase chain reaction 
(PCR) in Brucella spp. identification. Types of polymerase chain reaction include 
Standard PCR, Real-time PCR as well as Nested and Semi-nested PCR. For Standard 
PCR, according to Gupte and Kaur (2015), a PCR assay with one pair of primers was 
developed, which amplifies the target genomic sequence of Brucella species. Studies 
showed that standard PCR is a more sensitive technique than microbiological methods 
both in the diagnosis of the first episode of infection and early detection of relapses 
(Wang Y et al., 2014). 
 
For the quantification of nucleic acid in the blood samples of individuals, real-time PCR 
is used. This is sensitive, specific, rapid and highly reproducible (Wang Y et al., 2014). 
The nested PCR means that two different pairs of PCR primers are used for a single 
locus (Gupte and Kaur, 2015). Semi-nested PCR has two different pairs of PCR 
primers, but the second pair of primers has one primer identical to the first pair (Seah et 
al., 1995). Nested PCR and Semi-nested PCR assays are now developed for identifying 
Brucella in samples of human blood and then to explore their clinical practice for the 
diagnosis of human brucellosis (Gupta and Kaur, 2015). Lin et al. (2011) reported a 
nested PCR for the laboratory diagnosis of human brucellosis. Other PCR based 
assays include a combination of  Polymerase Chain Reaction and Enzyme 
Immunoassay (PCR-EIA) used by Vrioni et al.(2004) for the rapid laboratory diagnosis 
of human brucellosis directly from peripheral blood; and PCR-Restriction Fragment 
Length Polymorphism Assay (PCR-RFLP) for molecular typing of Brucella abortus and 
Brucella melitensis as used by Mirnejad et al.(2013) 
 
1.3.1.3 Loop-mediated Isothermal amplification (LAMP) for diagnosing human 
brucellosis 
Loop-mediated isothermal amplification is a single tube technique for the amplification 
of DNA. The technique involves isothermal nucleic acid amplification technique in which 
amplification is carried out at a constant temperature; but a thermal cycler is not 
required (Notomi et al., 2000). This assay is simple in operation, rapid, sensitive and 
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specific (Ohtsuki et al., 2008). In addition, LAMP is not expensive as its cost per sample 
is far cheaper than PCR and real-time PCR. Heat block or water bath (which are 
inexpensive) that provides a constant temperature of 63oC is sufficient for the assay, 
and the reactivity is directly observed with the naked eye eliminating the need for 
electrophoretic analysis, unlike PCR (Gupte and Kaur, 2015). Therefore, this assay 
method is of useful importance in epidemiological studies in countries with limited 
resources (Soleimani et al., 2013).  Loop-mediated isothermal amplification has been 
used in the brucellosis diagnosis by Ohtsuki et al, (2008) and Trangoni et al. (2015). 
 
1.3.1.4 Multiple Locus VNTR Analysis (MLVA) for diagnosing human brucellosis 
Multiple loci VNTR analysis (MLVA) is a method employed for the genetic analysis of 
particular microorganisms. It takes advantage of the polymorphism of tandemly 
repeated DNA sequences. A "VNTR" is a "variable-number tandem repeat". This 
method is well known in forensic science as it is the basis of DNA fingerprinting in 
humans (CDC, 2017). The strain and biovar typing of Brucella field samples isolated in 
outbreaks is useful for tracing back the source of infection and may be of help in 
differentiating between natural outbreak of brucellosis and bioterrorist attack in humans, 
as Brucella is a potential biological warfare agent. 
 
1.3.1.5  Serological tests for diagnosing human brucellosis 
Serological diagnosis of brucellosis was first carried out by Wright and Smith in 
1897using a simple tube agglutination test (Nielsen and Yu, 2010). Serological tests for 
diagnosing brucellosis include the use of Rose Bengal Plate Test antigen (RBPT), 
Standard Agglutination Test (SAT), 2-Mercaptoethanol (2-ME), Enzyme-Linked 
Immunosorbent Assays (ELISA) for the detection IgG, IgA, and IgM;  Buffered Antigen 
Plate Agglutination test (BPAT), Lateral Flow Assays, Fluorescence Polarization 
Assays, Immunocapture-agglutination Test (Brucellacapt), Chemiluminescence Assays, 
Coombs Test,  and Complement Fixation Test.  
 
The procedures of the various serological tests, according to Nielsen and Yu (2010), are 
divided into 2 categories: the conventional tests and primary binding assays. All 
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conventional tests rely on the antibody performing a secondary function, for instance 
fixation of complement while in primary binding assays the only function of the antibody 
is attachment to its antigen. ELISA is an example of primary binding assays for 
brucellosis with many authors reporting varying specificity and sensitivity for Brucella 
IgG ELISA and IgM ELISA. For example Mohraz et al. (2003) reported 100% and 93% 
for specificity and sensitivity respectively; Vakili et al. (2010) 70.6% and 93.7% for 
specificity and sensitivity; and Dashti et al. (2012) 85.38% and 84.09% for specificity 
and sensitivity. For IgM, Vakili et al. (2010) reported 100% and 12.5% for specificity and 
sensitivity respectively.  
 
Serological tests for the diagnosis of human brucellosis are not standardized 
internationally, though they seem to be effective. Another demerit of the use of these 
tests is the detection of antibodies in the sera of Brucella-positive individuals after 
successful therapy. Cross-reaction may also occur (Al Dahouk et al., 2013). 
 
In conclusion, definitive diagnosis of brucellosis is difficult.  No single test is perfect. 
Clinical history coupled with combination of two or more tests reduces diagnostic result 
errors (Gupte and Kaur, 2015).  Most researchers on human brucellosis in Nigeria used 
only Rose Bengal Plate test for diagnosing brucellosis in their studies.  Although the 
sensitivity of the antigen is high, the probability of false-negative result for this test is 
high in chronic conditions and complicated cases. The assay also gives false sero-
positives because of the cross reaction between Brucella species with antibodies to 
other organisms such as Yersinia enterocolitica and Afipia clevelandensis. In the light of 
these, this study will involve the use of Rose Bengal Plate Test antigen and subsequent 
confirmatory test by the use of Enzyme-Linked Immunosorbent Assay (ELISA) in order 
to reduce false diagnostic results among the test samples (Poester et al., 2010)   
 
1.4  PREVENTION AND TREATMENT OF BRUCELLOSIS 
1.4.1 Prevention in humans 
Brucellosis prevention in humans is best achieved by the eradication of the infection in 
animals, which are the primary hosts (Doerr, 2017). Animals meant for public 
8 
 
consumption should only be slaughtered at designated slaughter slabs and abattoirs so 
that adequate inspection of meat can be carried out by the veterinarians.  In addition, 
according to the World Health Organization, consumption of unpasteurized milk/milk 
products should be avoided. Also, avoidance of raw meat consumption, food and 
personal hygiene, regular hand washing, disinfection; and wearing of protective 
clothing/protective device for people working with animals or at Brucella-vaccine 
production center/laboratories are very important. Lastly, massive education/public 
awareness on the infection with community participation is also of utmost importance. 
Adequate knowledge of the infection by all (including the physicians/health workers) will 
help in curtailing the spread of the disease in humans (Swai et al., 2010) 
 
1.4.2 Prevention in animals 
In animals, prevention is the preferred approach. Brucellosis is a listed disease by OIE. 
Therefore, test and slaughter policy (with necessary compensation of the farmers) 
instead of treatment is the recommended approach for prevention of brucellosis (OIE, 
2018). In addition, vaccination of herd also prevents infection in livestock. Examples of 
vaccines currently being used for the various animals are live Brucella abortus vaccine 
strain RB51 (which replaced Brucella abortus vaccine strain 19), Brucella abortus 45/20, 
live Brucella melitensis vaccine strain Rev-1 and live Brucella suis vaccine strain 2. 
Though these vaccines are effective, they have numerous drawbacks such as causing 
abortion in pregnant dams and pathogenicity in humans (Dorneles et al., 2015). In 
addition, control of herd/animal movement, surveillance and farm sanitation is also 
helpful in the control of brucellosis in animals. 
 
1.4.3 Treatment of Brucellosis in humans  
The treatment of human brucellosis is dependent on the effective antibiotics 
administration over an adequate period of time (Corbel, 2006). In addition, therapy of 
brucellosis must be geared towards prompt control of symptoms as well as prevention 
of complications and relapses (Wafa, 2017).  
 
9 
 
Brucellosis is often difficult to treat because therapy takes many weeks; and often, more 
than one antibiotic is needed for treatment. Oral administrations of 100mg doxycycline 
twice daily for 6 weeks together with daily, parenteral administration of 1g streptomycin 
for 2-3 weeks are the World Health Organization recommended two-antibiotic treatment 
in adults for acute brucellosis. Alternatively, 100mg of doxycycline, given twice daily and 
600–900 mg rifampicin can be combined for oral treatment for a least period of 6 weeks 
(Vassalos et al., 2009). In uncomplicated human brucellosis in children of age eight and 
above as well as in adults, according to Corbel (2006), 500mg of tetracycline, given 
every six hours interval for a least period of six weeks is recommended. However, the 
tetracycline analogue-doxycycline is currently preferred over tetracycline because it 
causes fewer gastro-intestinal side effects when compared with tetracycline. 
Doxycycline is given alone in a dose of 100 mg every 12 hours orally and is 
administered for a period of six weeks. The relapse associated with single 
administration of tetracycline and doxycycline has led to most authorities recommending 
the combination of these drugs with an amino-glycoside such as streptomycin and 
gentamycin for the first two to three weeks of treatment. Secondary alternate therapies 
include Trimethoprim/sulfamethoxazole (TMP/SMZ, co-trimoxazole), and 
fluoroquinolones. However, there is high relapse when these drugs are used.  Hence, 
they are combined with the main drugs recommended by the World Health Organization 
(Corbel, 2006).  
 
In some cases such as spondylitis, cerebral or epidural abscess, endocarditis, splenic 
abscess and hepatic brucelloma, individualized treatments should be administered to 
the patients. For example, in spondylitis, quinolones which penetrate and achieve 
increased concentrations in bone and soft tissue; and which are supposed to shorten 
the length of treatment are administered. However, they are deemed inferior to other 
drugs (Skalsky et al., 2008; Pappas et al., 2004; Vassalos et al., 2009). Surgery can 
also be carried out in brucellosis patients with endocarditis, and hepatic brucelloma. 
Consensus recommendation on therapy of neurobrucellosis is still being desired; and 
more information on effective endocarditis treatment is needed (Vassalos et al., 2009). 
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1.4.4 Treatment of animal brucellosis 
Treatment of infected or suspected cases of animal brucellosis using antibiotics is not 
common and should not be considered in the control of the disease. Although few 
studies have shown rapid decline in the incidence of the infection when herd or flock 
were treated (like in the case of animals of special breeding value), however, the 
procedure is restricted in practice (Corbel, 2006). For example, treatment of Brucella 
canis infection is very difficult and expensive (Illinois Husbandry and Animal Welfare 
Association, 2015). Hence, the consensus is that vaccination is the best method for 
brucellosis prevention and control. 
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Table 1: Host preferences of Brucella 
Species Host preference 
Brucella abortus Cattle 
Brucella suis Pig 
Brucella melitensis Sheep, goat 
Brucella canis Dog 
Brucella ovis Sheep 
Brucella cetis Cetaceans 
Brucella neotomae Desert wood rat 
Brucella pinnipedialis Seals 
Brucella microti Common Voles 
 
With the exception of Brucella microti, Brucella neotomae, Brucella ovis and Brucella 
suis biovar 5, all other species of Brucella cause infection in humans (Lopes et al., 
2010). However, zoonotic potential varies among the species (Xavier et al., 2010). This 
is shown in Table 2 below. 
 
Table 2: Zoonotic potentials of Brucella 
Species Zoonotic potential 
Brucella melitensis High 
Brucella abortus Moderate 
Brucella suis Moderate 
Brucella canis Mild 
Brucella ovis Absent 
Brucella neotomae Absent 
Brucella ceti Mild 
Brucella pinnipedialis Mild 
Brucella microti Absent  
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1.5 LITERATURE REVIEW 
1.5.1 Global Report on the most common Zoonotic Brucella species 
1.5.1.1  Brucella abortus 
Brucella abortus was discovered in 1897 by Bernhard Lauritz Frederik Bang, the 
bacterium was then referred to as Bang‘s bacillus.  Later, the pathogen‘s name changed 
to Brucella abortus. In 1918, Alice Catherine Evans, an American microbiologist 
demonstrated the zoonotic capability of Brucella abortus and its close relationship with 
the bacteria isolated by Bruce.  The bacterium causes abortion and infertility in adult 
cattle (Dorneles et al., 2015). It also affects other domestic and wild animals namely 
buffaloes, deer, horses, dogs, camels, sheep, goats and man (Xavier et al., 2010; 
Dorneles et al., 2015).  Brucella abortus is the most widespread cause of brucellosis.  
Infection in man is often sub-clinical and usually  less  severe  than  that  caused  by 
either  Brucella  melitensis  or Brucella suis (Corbel, 2006).  Brucella abortus is 
classified into seven biovars; namely biovars 1-6 and biovar 9.  Within  the  last  two  
decades,  a number  of  developed  countries  have  eradicated,  or  significantly  
reduced,  the  prevalence of Brucella abortus infections (FAO, 2010). 
 
1.5.1.2  Brucella melitensis 
Brucella melitensis (B. melitensis) was discovered and isolated from the spleen of a 
man that died of ‗Malta Fever‘ in the year 1887 by David Bruce, the British army 
surgeon.  The pathogen was initially named Micrococcus melitensis (Galińska & 
Zagórski, 2013).  The mechanism of transmission was determined in 1905 by 
Themistocles Żammit who found that carrier goats could infect humans with 
Micrococcus melitensis via milk (Wyatt, 2005).  It is the most virulent of all the Brucella 
species in humans. A few organisms are sufficient to cause debilitating chronic infection 
(Fugier et al., 2007). This pathogen is the main cause of ovine and caprine brucellosis.  
However, susceptibility of sheep breeds varies greatly. Infections caused by B. 
melitensis have also been reported occasionally in cattle, camels and dogs; as well as 
in wild ruminants such as alpine ibex in Italy and chamois in the French Alps (Centre for 
Food Security & Public Health, 2009). However, the pathogen rarely infects horses and 
pigs (Centre for Food Security & Public Health, 2009). This species contains three 
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biovars- biovar 1, biovar 2 and biovar 3; and is very common in the Mediterranean 
region. B. melitensis biovar 3 was isolated from a Sable antelope in 2002 at 
Onderstepoort Veterinary Institute, Bacteriology section, South Africa by Prudence 
Kayoka-Kabongo (Personal communication, January 2018).  Brucella melitensis 
infection also occurs in the Central Asia, Middle East, around the Persian Gulf, Africa, 
some countries of Central America and India. The infection seems not  to  be  endemic  
in  northern part of  Europe,  Southeast Asia, North America (with the exception of 
Mexico), Australia, or New Zealand (Centre for Food Security & Public Health, 2009).  
 
1.5.1.3  Brucella suis 
Brucella suis (B. suis) was included in the genus Brucella in 1929 (Huddleson, 1929; 
Cabi, 2017).  It comprises five (5) biovars; with pigs being the most common host of 
biovars 1 and 3 which are distributed all over the world (Díaz, 2013; Cabi, 2017). Biovar 
1, which is the most widespread, is found in Australia, many Pacific Islands, the United 
States and Southern China (Diaz, 2013; Pedersen et al., 2014). Biovar 2 appears to be 
widely distributed from Scandinavia to the Balkans (Godfroid and Kasbohrer, 2002; Al 
Dahouk et al., 2005; Cabi, 2017); and is rarely pathogenic for humans, whereas biovars 
1 and 3 are highly pathogenic (in both pigs and humans), causing severe disease (OIE 
Terrestrial Manual, 2009).  Brucella suis biovar 4 is enzootic in reindeer and caribou in 
Arctic regions of North America and Europe. This biovar is apparently not pathogenic in 
swines, but it causes brucellosis in man (Cabi, 2017). Brucella suis biovar 5 is 
associated with murine brucellosis but has been rarely reported since initial description 
in the former Soviet Union (Cabi, 2017). 
 
Brucella suis continues to occur in domesticated herds in some countries of Central and 
South America; and Asia. Cases of B. suis infections are occasionally reported in some 
African nations, including Uganda and Cote d‘Ivoire (Centre for Food Security & Public 
Health, Iowa State University, 2009; Bello et al., 2012). There is no report of the 
pathogen in South Africa. 
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1.5.1.4 Brucella canis 
Brucella canis is found primarily in dogs, worldwide. It has been reported in United 
States (particularly the southern states), Canada, Central and South America (including 
Mexico), some European countries, China, Tunisia, South Africa,  Taiwan, Nigeria, 
Madagascar, Malaysia, Philippines, Malaysia, India, Korea and Japan (Centre for Food 
Security & Public Health, 2012). However, the Oceanian countries appear to be free of 
the pathogen. 
 
Brucella canis was firstly described in United States in 1966 following mass abortions of 
beagles (Morisset & Spink, 1969).  It is a zoonotic pathogen, though symptomatic 
human infections are rare. However, human infections with Brucella canis may be 
underdiagnosed which could explain its low prevalence or being rarely diagnosed 
(Centre for Food Security & Public Health, 2012; Krueger et al., 2014).  Cases of human 
B. canis infection have been reported in Argentina (Lucero et al., 2009), in Japan 
(Nomura et al., 2010) and United States (Krueger et al., 2014; Dentinger et al., 2015).   
 
1.5.1.5  Brucella ceti 
Miller et al. (1999) reported that Brucella species infections and related lesions have 
been found in marine mammals namely bottlenose dolphins (Tursiops truncatus); 
striped dolphins (Stenella coeruleoalba) (Gonzalez et al., 2002), Atlantic white-sided 
dolphins (Lagenorhynchus acutus) (Foster et al., 2002), common dolphins (Delphinus 
delphi), harbor porpoises (Phocoena phocoena) (Dagleish et al., 2008), and a minke 
whale (Balaenoptera acutorostrata) (Foster et al., 2002).   
 
Serological surveys have shown that cetacean brucellosis may be found all over the 
world in the oceans. Brucella ceti isolates have been included within the same species 
but there are three different groups based on preferred host, bacteriological properties, 
and distinct genetic traits: Brucella ceti dolphin type, Brucella ceti porpoise type, and 
Brucella ceti human type. It seems that Brucella ceti porpoise type is more closely 
related to Brucella ceti human isolates and Brucella pinnipedialis group, while Brucella 
ceti dolphin type seems ancestral to them.  The more likely mode of transmission of 
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Brucella ceti seems to be through mating, maternal feeding, aborted fetuses, placental 
tissues, vertical transmission from mother to the fetus or through fish or helminth 
reservoirs. The Brucella ceti dolphin and porpoise types seem to display variable 
virulence in land animal models and low infectivity for humans.  
 
1.5.1.6  Brucella pinnipedialis 
Brucella pinnipedialis is the aetiological agent of brucellosis in seals.  Seals are 
pinnipeds. Pinnipeds, also known as fin-footed mammals, are a widely distributed and 
diverse group of fin-footed marine mammals, which are semi-aquatic comprising the 
families Odobenidae.  Distribution of the diseases in seal is worldwide.  The disease 
can also be transmitted to humans from seals. 
 
1.5.2 ANIMAL BRUCELLOSIS IN AFRICA 
Brucellosis is widespread in Africa (Ducrotoy et al., 2014; Ducrotoy et al., 2017; Mangen 
et al., 2002; McDermott et al., 2013); and is endemic within most African countries 
(Akakpo & Bornarel, 1987; McDermott and Arimi, 2002; Aworh et al., 2013). The 
condition is often under-reported due to limitations in diagnostic tools and facilities 
(Ducrotoy et al., 2017).  
 
In Egypt (North Africa), brucellosis is prevalent in many species of farm animals in all 
parts of the country (Wareth et al., 2014). In a research work covering Kenya and 
Tanzania, East Africa by Chota et al. (2016), it was reported that brucellosis was 
endemic in both countries when different serological diagnostic techniques were used in 
ascertaining the prevalence of the infection among 2349 ruminants. Results showed a 
sero-prevalence of 11.4% in the Southern Highland Zone (n=799), 2.4% in the Eastern 
Zone (n=169) and 1% in the Northern Zone (n= 408) when Rose Bengal plate test was 
used together with competitive enzyme linked immune-sorbent assay (c-ELISA) as 
confirmatory test.  Tasiame et al. (2016) got a sero-prevalence of 22.9% out of 315 
cattle which were subjected to Rose Bengal Plate test in North Tongu district of Ghana 
in West Africa. Bovine brucellosis has also been reported by Nakoune et al. (2004) in 
Central African Republic (4.9%); Bayemi et al. (2009) in Cameroon (8.4%); and 
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Mekonnen et al. (2010) in Ethopia (4.9%). Outbreaks of animal brucellosis in South 
Africa have been reported between 1993 and 2014 by Mbizeni (2015).  All these reports 
confirm the existence of brucellosis in Africa. 
 
1.5.3  Human brucellosis in Africa 
Human Brucellosis is considered endemic in Africa (Tuncel et al., 2008). Pappas et al. 
(2006) reports on human brucellosis divided the continent into two: North Africa and 
Sub-Saharan Africa. The northern part of Africa has traditionally been considered 
endemic for brucellosis. However, the disease also exists in Sub-Saharan Africa. There 
are many reports of brucellosis in various parts of Africa. For example, Tasei et al. 
(1982) reported that the disease is spread throughout Mali.   They reported a high 
prevalence rate of 24.4% in the Sahelian region of Gourma. This report was 
corroborated by another research by Dao et al. (2009) which revealed that of the one 
hundred and fifty (150) sera samples from individuals in Mopti city, 58% tested positive 
for Brucella melitensis while 49% tested positive for Brucella abortus. Besides this 
report, another serological survey conducted by Fayomi et al. (1987) in Republic of 
Bénin showed that of the 221 sera from exposed workers in slaughtering-houses and 
breeders tested with Rose Bengal test, Wright sero-agglutination test, indirect 
immunofluorescence test and counter-immuno electrophoresis , 17.7% were positive to 
the disease‖. In Ethiopia, Regassa et al. (2009) reported the occurrence of the disease 
in traditional pastoral communities in people with recurrent unresolved febrile illness. 
Kassahun et al. (2006) had earlier reported a brucellosis prevalence rate of 4.8% 
among three hundred and thirty six (336) individuals that worked at Addis Ababa 
abattoirs and different dairy farms in the same country. In Akwapim-south District of the 
Ghana, Kubuafor et al. (2000) reported no incidence of human brucellosis in their 
research work, although there was 6.6% prevalence of Brucella abortus in cattle. 
Mensah et al. (2011) also reported low incidence of human brucellosis among 
herdsmen and the members of their family in the coastal savanna of Ghana. However, 
McDermott and Arinmi (2002) reported that human brucellosis might probably be 
endemic in Ghana and Togo. In Egypt, Hassanain and Ahmed (2012) reported a sero-
prevalence of 6.26% out of four hundred and seventy nine (479) animals-contact 
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persons tested for the infection. Brucellosis is considered a health hazard in Egypt, 
especially in the rural areas. In Kenya, although there is no adequate record of 
brucellosis, Muriuku et al. (1994) showed that brucellosis occurred throughout the years 
within a seven-year report of 1986-1992 in Narok District. Rujeni (2007) reported a sero-
prevalence rate of 25% in pregnant women in Rwanda. 
 
1.5.4  Animal Brucellosis in Nigeria 
The first report of brucellosis in Nigeria was of ten cases of bovine brucellosis 
(Contagious abortion) in 1927. Reports dating back to 1960s revealed that brucellosis 
disease in animals and humans is endemic in Nigeria (Adams and McKay, 1966; Alausa 
and Awoseyi, 1976). Esuruoso, (1979) reported the disease in goats, sheep, cattle, pigs 
and dogs.   
 
Slaughter surveillance and serological testing of local and exotic breeds of cattle across 
the nation, particularly in ranches, livestock centers and dairy farms showed prevalence 
rate ranging between 3.7 - 48.8%.  A prevalence of 7.1 - 8.6% was also recorded in 
unvaccinated nomadic herds, and as high as 26% in cattle concentrated around 
watering points, particularly among extensive management systems (Rikin, 1988). 
Cadmus et al. (2006) reported serological prevalence rate of between 0.20% and 
79.70% in the various parts of the country up to Year 2006. Ocholi et al. (2005) reported 
Brucella abortus infection in sheep (which is naturally acquired and sporadic) on a 
privately owned farm in Toro, Bauchi State, northeast Nigeria. The abortions occurred in 
a flock of twenty-eight Yankassa breed of sheep, involving five ewes at the third month 
of pregnancy. Serum and milk samples from the flock were examined for Brucella 
antibodies by the Rose Bengal plate test, serum agglutination test (SAT) and milk ring 
test (MRT). The SAT gave 14.3% prevalence rate. The five milk samples examined by 
Milk Ring Test were positive. Out of three of the milk samples and four vaginal swabs of 
ewes that had aborted, seven isolates of Brucella abortus biovar 1 were identified and 
biotyped. This biovar was also isolated from cattle reared with sheep on the same farm. 
This is a proof of cross infection of Brucella organisms among animals in Nigeria. In 
addition, Onoja et al. (2008) reported a prevalence rate ratio of 1 (0.8%) in ram to 12 
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(69.2%) in ewes (and overall prevalence rate of 76%) in a flock of seventeen sheep in 
Zaria, which is located in the north central part of the country.  
 
A sero-epidemiological study of brucellosis in sheep and goat, carried out in Plateau 
state, in the same north-central geo-political zone of Nigeria, showed that out of a total 
of 1,347 serum samples (n = 851 goats and n= 496 sheep) collected from nine 
randomly selected Local Government Areas, the prevalence rate was 14.5% in sheep 
and 16.1% in goats (Bertu et al., 2010). In cattle, Cadmus et al. (2009) reported a 
prevalence rate of 8.6 ± 1.78% out of a total of 479 cattle slaughtered at two major 
abattoirs in Lagos State, whereas Mohammed et al. (2011) reported prevalence rate of 
4.04% (23 cattle) and 3.86% (22 cattle) out of a total 570 cattle when Rose Bengal Plate 
Test and c-ELISA were used respectively and simultaneously in Jigawa State. Jigawa is 
located in the North-eastern part of Nigeria. A similar study on the sero-prevalence of 
brucellosis in puerperal cows in Zaria Nigeria by Ate et al. (2007) revealed that about 
67% of the herds studied were sero-positive for brucellosis, when Rose Bengal plate 
agglutination test was carried out. This disease prevalence was higher than in post-
partum cows.  
 
In birds, the incidences of brucellosis have also been reported in Nigeria. These include 
detection of Brucella melitensis in local chicken in Sokoto, North-western Nigeria by 
Junaidu et al. (2006). Out of one thousand local chicken birds that were subjected to the 
Rose Bengal Plate test, serum agglutination test (SAT) and competitive ELISA 
(Compelisa) using both Brucella abortus and Brucella melitensis antigens, 30 (3.0%), 28 
(2.8%) and 26 (2.6%) were positive for Brucella melitensis respectively. A similar study 
by Alaga et al. (2012), aimed at detecting agglutinating antibodies to Brucella organisms 
in pigeons, local chicken and Muscovy ducks in Nasarawa State, North Central geo-
political zone, revealed that of 1120 birds of both sexes (n= 355 pigeon, n=510 local 
chickens and n=255 Muscovy ducks), the prevalence rate was 2.8%, 2.3% and 1.9% 
respectively, when the sera were tested using Rose Bengal Rapid Plate Agglutination 
Test (RBB-RPAT). Gugong et al. (2012) also carried out a study to assess the status of 
brucellosis in local chickens in four Local Government Areas of Kaduna state, Nigeria.  
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A total of 150 sera sample were tested, with one (0.67%) being positive for Brucella 
antibodies on the Rose Bengal Plate Test (RBPT). In the south-eastern part of the 
nation, Onunkwo et al. (2011) reported 0.6 % brucellosis prevalence in pigs. 
 
Livestock brucellosis is endemic in Nigeria. Unfortunately, there is no national control 
programme for the disease in both animals and humans. Nigeria is one of the countries 
with highest zoonosis burden and widespread mortality/morbidity in the world (ILRI, 
2012), with brucellosis being one of the zoonotic diseases. 
 
1.5.5 Human Brucellosis in Nigeria 
Nigeria, together with Ethiopia and India, have the highest zoonotic burden in the world, 
with brucellosis being one of the most important zoonosis in terms of human and 
livestock impact. Brucellosis is one of the zoonotic diseases often neglected by primary 
healthcare managers and policy makers in the country (Ehizibolo, 2011).  Furthermore, 
there are few publications on the prevalence of human brucellosis in Nigeria.  In 
addition, major gaps exist in epidemiological data, diagnostics, control, and 
misconceptions surrounding brucellosis in the country.   
 
Almost 100 years after the first brucellosis control programme was established in 
Nigeria, there is absence of good-quality information, which is essential for evaluation of 
zoonotic potential and for establishment of control measures (Ducrotoy et al., 2014). 
The government appears not to perceive the health risks and implications of brucellosis 
on livestock/animal productivity. This is alarming, in the light of reported prevalence 
range of 6-28% among hospital patients; and 28-57% among abattoir workers in the 
country (Collard 1962; Falade 1974; Falade 1978; Ocholi 1993; Asanda and Agbede, 
2001) 
 
The first cases of human brucellosis confirmed by laboratory tests were reported in 
1941 and 1962 respectively (Elmes, 1941; Collard, 1962). During this period, under 
detection was suspected (Collard, 1962). Years later, few laboratories were established 
to carry out tests on brucellosis but the low specificity of the diagnostic tests available 
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then could have missed positive cases (Alausa and Osoba, 1975).  Alausa (1977) 
stated that 60% of the human population in Nigeria show serological evidence of 
Brucella abortus infection. Higher antibody titre values were found among 
occupationally exposed people, than the general population of blood donors.  
 
In addition, the incidence and level of human infection was significantly higher in people 
living in the northern parts of the country than those living in the western area of the 
country. This may be due to the frequent physical contact by northern Nigerians with 
livestock because of the high animal population in the region.  
 
Other historical evidence of human brucellosis in the country as reported by Ducrotoy et 
al. (2014) was in the 1970s when there was widespread epidemic of bovine brucellosis. 
The Fulani herdsmen, who reared the animals, complained of being unwell and were 
unable to look after their cattle. Falade (1974) also reported occurrence of Brucella 
agglutination antibodies in the sera of some people from Ibadan and its surrounding 
districts, located in the south-west region of the country. Other human brucellosis 
research work in Nigeria include the study of Baba et al. (2001) in which patients with 
pyrexia of unknown origin were tested for the presence of Brucella abortus antibodies 
using RBPT and SAT tests at Maiduguri, Northeast Nigeria. Sero-positive prevalence 
rate of 5.2% (26) were reported among 500 patients. Cadmus et al. (2006) in Ibadan, 
Southwest Nigeria, got 31.82% (7) sero-positive prevalence rate (using Rose Bengal 
Test) among butchers; while Ofukwu et al. (2007) research work on patients with febrile 
illnesses at Federal Medical Centre, Makurdi, North Central part of the country over a 
12 months period revealed overall prevalence of 7.6% out of sera samples of 1040 
individuals screened using Rose Bengal Plate test and SAT test simultaneously. The 
infection in the sero-positive individuals were caused by Brucella abortus (77.2%) and 
Brucella melitensis. (22.8%).  In the same geo-political zone of the country, Gusi et al. 
(2010) got a prevalence rate of 5% (9 butchers) and 3.9% (4) when Rose Bengal Plate 
test and SAT test were used respectively for the sero-diagnosis of brucellosis among 
101 butchers at Jos abattoir, Plateau State. However, Olabode et al. (2012) study 
efforts to determine infection with brucellosis among women that process meat to form 
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‗siki‘, a local delicacy at Ilorin; Kwara State was unsuccessful as the women did not 
subject themselves to sera samples collection.  Relatively, recent research work by 
Aworh et al. (2013) at two abattoirs located in the Federal Capital Territory, Abuja 
(which is the national capital of the nation) involving 224 abattoir workers led to the 
observation of a prevalence rate of 24.1% when the workers were screened for Brucella 
abortus and Brucella melitensis antibodies. Meanwhile Kudi et al. (2015) got a 
prevalence rate of 32.5% out of 246 sera samples obtained from patients with febrile 
illness symptoms such as malaria and typhoid between 2012 and 2014 at General Out-
Patient unit, Federal Teaching Hospital, Gombe, Northeast Nigeria.  Aworh et al. (2013) 
used ELISA and Rose Bengal plate antigen for their research work while Kudi et al., 
(2015) used Rose Bengal plate antigen alone. In summary, human brucellosis is 
suggestively endemic in Nigeria.  
 
1.6  BRUCELLOSIS OUTSIDE THE AFRICAN/OTHER CONTINENT  
1.6.1  Europe 
Brucellosis infection in Europe is mainly in the Mediterranean countries. The 
Mediterranean European countries refer to Southern European countries such as 
Greece, Albania, Macedonia, Spain, Portugal, Andorra, Italy, Bulgaria, Serbia and 
Malta. However, the epidemiology of the disease has been changing over the past 
decade because of socio-economic, sanitary and political factors; as well as 
international travel (Tzaneva et al., 2009; Pappas et al., 2006). The disease is endemic 
in the region.  According to Lytras et al. (2016), the country with the highest reported 
incidence of brucellosis in the European Union is Greece. He further stated that human 
brucellosis cases of 2159 were reported in Greece between November 2013 and 
December 2015. The mean incidence rate was 1.62 per 100 000 population per year, 
with Brucella melitensis being the most common pathogen in the country (Taleski et al., 
2002). It must be noted though, that there are reported cases of Brucella abortus 
infection in the ancient nation too (Giannakopoulos et al., 2006; Stephen Berger, 2017).  
However, most Islands in the country enjoy a brucellosis eradication status as at June 
2009 (Karagiannis, 2009).  
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In Italy, the incidences of human brucellosis have been on a decline as reported by De 
Massis et al. (2005) and Mancini et al. (2014). Brucellosis is still a common notifiable 
disease in the country, more widespread in southern regions of Italy, especially in Sicily, 
(including Apulia, Campania, Calabria), in human, sheep and goat populations (De 
Massis et al., 2005). Rapisarda et al. (2005) reported five cases of Brucella infection 
due to occupational exposure in a slaughter-house in South-Eastern Sicily, Italy. The 
five individuals consisted of four slaughter-house operators and a veterinary surgeon.  
 
Brucellosis is also endemic in Turkey (Yumuk and O‘Callaghan, 2012), although the 
country lies in Eurasia region. In 2014, 354 confirmed cases of brucellosis were 
reported by 18 European Union and European Economic area (EU/EEA) countries, with 
an overall rate of 0.1 per 100 000 population.  Eleven Member States reported zero 
cases, while Greece, Spain and Portugal reported the highest numbers of cases (135, 
60 and 50, respectively), corresponding to 69.2% of all cases reported in EU and EEA 
(European Centre for Disease Prevention and Control, 2016).  
 
Many EU and Western Europe countries have been granted brucellosis-free status. 
Countries with brucellosis-free status include Belgium, Netherland, Sweden, Denmark, 
UK (excluding Northern Ireland), Finland, Austria, Germany and Luxembourg. Norway 
and Switzerland are not part of the EU countries, but are also considered as brucellosis-
free state (Pappas et al., 2006).  
 
It must be noted however that small number of brucellosis cases are still being reported 
annually in most of these countries, mainly in travellers to endemic countries or 
immigrants from endemic areas (Al Dahouk et al., 2005; Pappas et al., 2006; Norman et 
al., 2016). Also, countries such as France and UK which were previously declared as 
brucellosis-free countries have experienced re-emergence of the disease (Mailles et al., 
2012) and UK (MRCVSonline, 2017). 
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In conclusion, according to European Centre for Disease Prevention and Control 
(2016), brucellosis remains a rare disease in the EU/EEA, although it is still found in 
some countries in the continent, with Brucella melitensis and Brucella abortus being the 
common cause of the infection. 
 
1.6.2  Brucellosis in Asia 
Brucellosis is endemic in the Middle East, Central and South East Asia. Rubach et al. 
(2013) reported that the Middle East and Central Asia have the highest reported 
incidence of human brucellosis all over the world. Incidence rates of more than 100 in 
100,000 person-year was reported in Saudi Arabia, Jordan and Iraq.  In Saudi Arabia, 
infection of humans by Brucella melitensis is common (80%–100%), while infection with 
Brucella abortus is less frequent (Al-Eissa, 1999; El-Koumi et al., 2013). However, 
infection with other species has not been reported (Al-Eissa, 1999; El-Koumi et al., 
2013).  
 
The people are commonly infected through direct contacts with infected animals, 
inhalation of infectious aerosols (for example workers in abattoirs and microbiological 
laboratories), consumption/ingestion of cheese, meat or raw milk; and products 
discharged by animals, which include conception discharge (among farmers, 
veterinarians and shepherd). (El-Koumi et al., 2013; Young, 2004).  For example, Al-
Sekait (1993) reported a prevalence rate of 4% among 1200 abattoir workers in the 
same country. Also in Saudi Arabia, Khan et al. (2001) wrote about the incidence of 
spontaneous abortion and intrauterine death among a retrospective cohort of 92 
pregnant women with acute brucellosis. Brucella melitensis was the primary cause of 
the infection, and the prevalence rate was 46%. It was observed that the rates of 
spontaneous abortion and intrauterine death was substantially higher in women that had 
acute brucellosis infection than the general population of pregnant women at their 
institution during corresponding pregnancy trimester. Majority of these women are older 
than 20 years of age, not primigravid and had not experienced spontaneous abortion 
prior to the time of the research study.  
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In Iraq Kurdistan, Jaff (2016) reported that the prevalence of human brucellosis in the 
three provinces was high. Prevalence rate of 6.36% was reported in Dohuk in 
2011(Omar et al., 2011); 10.7% in Erbil city (Rasul & Mansoor, 2012). 976 cases were 
recorded in Sulaimani province in 2013. This record is the highest incidence of 
brucellosis infection in Kurdistan region and Iraq as a country (Mohammed, 2015; Jaff, 
2016). Moreover, human and livestock infections exist in all governorates of the country 
(Karaawi, 2016); with Brucella melitensis and Brucella abortus being the common 
species of Brucella found in Iraq. Al-Tawfiq and Abukhamsin (2009), Abu Shaqra (2000) 
and Yacoub et al. (2006) also reported high incidence of human brucellosis in Central 
Asian countries such as Azerbaijan and Kyrgyzstan. As in the European Mediterranean 
countries, brucellosis exists in the corresponding Asian nations.  
  
In Israel, most reported cases were due to Brucella melitensis, biovar 1 in southern 
Israel, and biovar 2 in northern Israel (Banai, 2010).  Mongolia has one of the highest 
reported human incidence rates of brucellosis - greater than 60/100 000 people (Roth, 
2010). Sero-prevalence rate of 40.8% (1080) out of 2648 individuals were reported in 
Xianjing China.  These individuals were all infected by Brucella melitensis biotype 3 
(Guoqiu et al., 2013).  
 
Quazilbash and Bari (1997) also worked on sero-prevalence of human brucellosis 
among tuberculosis suspected patients in Islamabad, Pakistan.  Of the tested samples, 
44 (19.21%) were positive for brucellosis, using SAT. Majority of these people were 
from the rural areas. Brucellosis frequency among these tuberculosis suspected 
patients was found to be higher in women (73.91%) in comparison to the men (52.38%). 
Syria has one of the highest annual incidences of brucellosis worldwide, with alarming 
cases of 1603/million per year, according to the data from OIE (World Organization for 
Animal Health, 2004). 
 
Although brucellosis is a common human disease in many parts of Asia, investigation of 
cases is not commonly practiced in the Asian-pacific countries, despite the seriousness 
of the reports (Garin-Bastuji et al., 2014). 
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1.6.3 Brucellosis in South and Central America 
Human brucellosis is a disease that is also considered to be endemic in South America. 
Brucella melitensis is prevalent in Peru and West Argentina; and Brucella abortus in 
East Argentina (Trujillo et al., 1994; Samartino, 2002; Nöckler et al., 2009) and other 
South American countries (Pappas et al., 2006). Mexico is also one of the most 
important human brucellosis reservoirs (Pappas et al., 2006). In Central America, there 
is existence of animal brucellosis throughout the area (Moreno, 2002), but the human 
disease is not endemic.  
 
The global map of brucellosis as presented by Pappas et al., (2006) is shown below. 
 
Table 3: Annual cases of brucellosis by countries (Pappas et al., 2006) 
Country and Reference Incidence per million of population 
Europe 
 
Albania 63.6 
Bosnia and Herzegovina 20.8 
Denmark 0.7 
France 0.5 
Former Yugoslav Republic of Macedonia 148 
Georgia 27.6 
Germany 0.3 
Greece 20.9 
Ireland 1.3 
Italy 9 
Netherlands 0.5 
Norway 0.7 
Portugal 13.9 
Russia 4.1 
Serbia and Montenegro 8.4 
Spain 15.1 
Sweden 0.3 
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Switzerland 1.5 
UK 0.3 
Africa 
 
Algeria 84.3 
Cameroon Endemic, no specific data available 
Egypt 2.95 
Eritrea 5.48 
Ethiopia Endemic, no specific data available 
Mali 2 
Namibia 4.9 
Tunisia 35.4 
Uganda 0.9 
North America 
 
Canada 0.09 
USA 0.4 
Mexico 28.7 
Central and South America 
 
Argentina 8.4 
Chile 0.6 
Colombia 1.85 
Guatemala 15.7 
Panama 10.1 
Peru 34.9 
Asia 
 
Afghanistan 3.8 
Armenia 31.3 
Azerbaijan 52.6 
China 8 
India No data available, possibly endemic 
Iraq 278.4 
Iran 238.6 
Israel 9.2 
Jordan 23.4 
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Kazakhstan 115.8 
Korea, South 71 
Kuwait 33.9 
Kyrgyzstan 362.2 
Lebanon 49.5 
Mongolia 605.9 
Oman 35.6 
Pakistan No data available, possibly endemic 
Saudi Arabia 214.4 
Syria 1603.4 
Tajikistan 211.9 
Turkey 262.2 
Turkmenistan 51.5 
United Arab Emirates 41 
Uzbekistan 18 
Oceania 
 
Australia 26 
 
 
1.7  PATHOGENESIS OF BRUCELLOSIS 
The phagocytic macrophages, the antigen presenters-dendritic cells (DCs) and 
trophoblasts (cells that make up the outer layer of a blastocyst, responsible for embryo 
feeding and which develop into the large part of a placenta) are the major target cells for 
Brucella micro-organisms.  Brucella micro-organisms are capable of invading epithelial 
cells of the host; usually through the alimentary canal (Invasion through the digestive 
tract is associated with epithelial transmigration of bacteria preferentially through M 
cells). Intra-epithelial phagocytes may also transport Brucella from the intestinal lumen 
to the lamina propria (Figure 1) (Ackermann et al., 1988; Salcedo et al., 2008 and 
Xavier et al., 2010). Brucella organisms can also gain entry through the respiratory 
tracts and can survive in both phagocytic (Celli, 2006; Xavier et al., 2010) and non-
phagocytic host cells by finding ways to avoid the immune system (Xavier et al., 2010; 
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Wafa, 2017). Therefore, these bacteria can affect almost all organ system of the body. 
Hence, it is a systemic disease.  
 
Once Brucella gains entry into the bloodstream, the organisms become intracellular 
pathogens, found in circulating granulocytes or polymorphonuclear, leucocytes and 
macrophages. Many mechanisms are used to suppress or avoid bactericidal responses. 
The lipopolysaccharides (LPS) coat (smooth in Brucella melitensis, Brucella abortus, 
and Brucella suis; and rough in Brucella canis) is likely to play a major role in the 
intracellular survival of the micro-organism. This could be due to the inhibition of 
phagosomal fusion and the oxidative burst process as a result of adenine and guanine 
monophosphate production.  
 
Inside the agranular (mononuclear phagocytic) cells, Brucella micro-organisms are 
found in Brucella-containing vacuole (BCV), which is a special vacuole where it modifies 
intracellular trafficking and changes the vacuole into a brucellosome, a replicating 
compartment (Lamontagne et al., 2009; de Figueiredo et al., 2015).  
 
The micro-environment in the BCV has limited nutrients availability as has been shown 
experimentally (Lamontagne et al., 2009). The organism adapts to this environment 
soon after invasion (de Figueiredo et al., 2015). The adaptation of the organism include 
the switching to alternate sources of energy and the altering of the respiration process 
as a result of low oxygen tension (this is made possible as a result of quantitative 
reduction of gene expression and protein synthesis involved in anabolic mechanism 
while amino acid catabolism is being increased). Over time, the brucellae organisms 
recover gradually the expression of key metabolic process-encoded genes (de 
Figueiredo et al., 2015). The BCV invaginates with endoplasmic reticulum in epithelial 
cell lines, macrophages and placental trophoblasts (Anderson and Cheville, 1986; 
Pizarro-Cerdá et al., 1998; Celli et al., 2003 and Xavier et al., 2010), with chronic 
infection being established once they are in the compartment. 
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In conclusion, Brucella lacked classical virulence factors in bacteria such as cytolysins, 
exotoxins, plasmids, fimbriae, capsule, lysogenic phases as well as inducers of 
apoptosis in host cells among others (Moreno and Moriyón, 2006; Poester et al., 2013); 
but it is still able to replicate intracellularly. Its virulence are functions of two-component 
system BvrR/BvrS (TCS BvrRS; necessary for the modulation of the host cell 
cytoskeleton and regulation of the expression of outer membrane protein); the type IV 
secretion machinery VirB (T4SS VirB) (O‘Callaghan et al., 1999; Hong et al., 2000 and 
Poester et al., 2013) and Cyclic β-1, 2-glucans (CbetaG) which is produced by the 
organism for the targeting of its replication niche- endoplasmic reticulum of the host 
species (Poester et al., 2013). 
 
 
Figure 1: Schematic representation of Brucella invasion through the digestive tract.  Entry is 
through M cells and subsequently the bacteria are taken up by macrophages of the mucosa 
associated lymphoid tissue (MALT). This macrophage transports the bacteria to the lymph nodes 
and on to systemic sites. Blown up macrophage shows trafficking within the macrophage from 
entry via lipid rafts, through the endosomal pathway to the ER-like compartment in which Brucella 
replicates (Starr et al., 2008). In red letters are Brucella virulence factors that are involved in 
establishing (Xavier et al., 2010) 
 
1.8  PATHOGENESIS AND CLINICAL SIGNS OF BRUCELLOSIS  
1.8.1  Pathogenesis and clinical signs of bovine brucellosis 
Brucella abortus is the main cause of brucellosis in cattle. It also affects deer, camels, 
sheep, goat, horses, dogs, buffaloes and man (Xavier et al., 2010). The presence of the 
pathogen in affected host is noticed at the time of calving or in aborted cows. Clinical 
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signs of the infection in cattle include retained placenta after birth, post-partum metritis, 
mastitis, orchitis in the bull, arthritis, weak calves, inflammation of the epididymis, still 
birth; and male infertility. 
 
Spontaneous abortion in cows and other animals due to Brucella infections is because 
of lack of anti-brucella activities in the amniotic fluid. In addition, the presence of 
erythritol (a four carbon sugar that is preferentially utilized by the pathogen; which 
promotes placental and foetal infections) in the placentas of cows (cattle), dams (goats) 
and sow (pigs) cause the accumulation of Brucella organisms in the organ, thereby 
leading to the foetal abortion. This was confirmed by prior research by Xavier et al. 
(2010), in which it was reported that Brucella abortus induced abortion is associated 
with necro-hemorrhagic placentitis and fetal lesions, particularly fibrinous pleuritis, 
pericarditis, and interstitial pneumonia. 
 
Transmission of bovine brucellosis to healthy flock mainly occurs when there is 
exposure to aborted foetus, contaminated foetal membranes or uterine secretions from 
infected cows. Infected bulls do not usually play major role in the spread the disease. 
 
1.8.2  Pathogenesis and clinical signs of porcine brucellosis 
Brucellosis affects both domestic and wild pigs. The infection is caused by Brucella suis. 
The clinical signs of the disease in sows are abortion in various stages of gestation, 
irregular oestrus, infertility, metritis, and birth of weak piglets with a high neonatal 
mortality rate. In boars, orchitis, epididymitis, paralysis, abscesses in various organs, 
arthritis, osteomyelitis, spondilytis and sterility are the symptoms of the disease (Cabi, 
2017)  
 
It must be noted that swollen joints and tendon sheaths, which is followed by lameness 
and incoordination, can occur in both boars and sows (Lopes et al., 2010). The infection 
occasionally may be restricted to sexual glands and may not result in impaired fertility 
(Vandeplassche et al., 1967); while in some cases, fertility of the pigs is permanently 
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impaired, particularly in boars (Cabi, 2017). However, because porcine brucellosis does 
not often manifest clinical signs, diagnosis of the infection in pigs is usually difficult. 
 
1.8.3  Pathogenesis and clinical signs of caprine brucellosis 
The infection is primarily caused by Brucella melitensis. However, goats, which are the 
main hosts, are also susceptible to Brucella abortus infection (Wareth et al., 2015 and 
Rossetti et al., 2017) and Brucella suis (Alton, 1990). The main signs of brucellosis in 
goats are similar to that of other livestock. These include orchitis, epididymitis, sporadic 
fever, nervousness, mastitis, stiff/swollen joints and abortion at around the fourth month 
of pregnancy in the herd. Reduced milk yield, retained placenta, production of weak kids 
as well as still births are also symptoms of the disease in the animals. Mode of 
transmission of Brucella infection in goat is through vaginal discharges from infected 
animals, aborted foetus, amniotic fluids and placenta. Most animals become infected by 
ingestion or through the    mucous    membranes    of    the    oropharynx,    upper 
respiratory tract and conjunctiva. Brucella can also be transmitted through broken skin 
(Centre for Food Security & Public Health, 2009). The mucous membranes of the male 
or female genital tract are also other potential routes of infection. In addition to other 
route of infection, Brucella melitensis can also be transmitted by stable fly. To establish 
infection in the host, genes that encode urease are necessary (these genes are also 
important for the establishment of infection caused by Brucella suis and Brucella 
abortus). 
 
1.8.4  Pathogenesis and clinical signs of canine Brucellosis 
Brucella canis bacterium primarily affects the reproductive organs of male and female 
dogs. Brucellosis can infect dogs of any breed and any age; though it is most common 
in mature dogs. The infection causes infertility, late abortions (49th-59th day of 
gestation) and vaginal discharges in female dogs. In male dogs, it can cause 
inflammation of the testes or scrotum; as well as infertility. This disease can also lead to 
still birth or weak puppies at birth. Other symptoms of the infection in dogs include 
swollen lymph nodes, difficulty in walking, back pain, vaginal discharge and lethargy. 
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The Centre for Food Security & Public Health (2012) reported the symptoms of the 
disease in dogs to include abortions, stillbirths, and epididymitis, orchitis and sperm 
abnormalities in dogs. Castrated dogs do not show reproductive signs, but they 
occasionally develop conditions such as discospondylitis and ocular infection. There is 
also the occurrence of premature aging in infected dogs.  
 
Although Brucella canis infection is also found in other canids such as foxes, wolves, 
coyotes, dingoes and jackals, it is rarely reported. In addition, infection with other 
Brucella species such as Brucella suis and Brucella abortus have been reported in 
wolves, foxes and coyotes (Davis et al., 1979; Urbigkit, 2010; Azevedo et al., 2009). 
 
 1.8.5  Clinical Signs of Human Brucellosis 
Because of the wide spectrum of the clinical signs of human brucellosis, it has been 
grouped alongside tuberculosis and syphilis (Andriopoulos et al., 2007; Mantur et al., 
2006; Giannakopoulos et al., 2006). However, according to Celebi et al. (2007), 
brucellosis may be asymptomatic. Symptoms of brucellosis in humans are generally 
non-specific, as most of the signs are obvious in 50% or slightly lower percentage of 
patients (Pappas, 2008). The onset of brucellosis may be either acute or insidious. The 
latter mode of presentation causes more difficulties in diagnosis.  
 
The diverse and sometimes deceptive way the disease manifests (i.e. can be localized, 
acute, sub-acute or chronic infection) may lead to missing or delaying the diagnosis if 
the attending clinician has a low index of suspicion. Symptoms may appear suddenly 
over 1-2 days or gradually over 7 days or more.  Fever (which is classical undulant; with 
other patterns being manifested at other times) is commonly observed in 90-95% of the 
patients, and the infection is a differential in pyrexia of unknown origin.  
 
Other symptoms and the rate of occurrences in patients as reported by Willacy (2010) 
are malaise (80-95% of patients), tiredness and arthralgias (in 20-40%), chills, sweating 
(in 40-90%) and myalgias (in 40-70%). Athuri et al. (2011) observed the following 
symptoms: acute undulating fever (>90% of all cases), headache, arthralgia (>50%), 
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night sweats, fatigue and anorexia. Complications, which may arise thereafter, are 
epididymoorchitis, spondylitis, abscess formation in the liver, endocarditis and 
neurobrucellosis.  Kyebambe et al. (2012) report cervical spondylitic myeloradiculopathy 
as a symptom in a Ugandan teenager.   
 
The World Health Organization describes the infection as one with acute or insidious 
onset; continued intermittent or irregular fever of variable duration, profuse sweating, 
fatigue, anorexia, weight loss, headache, arthralgia and generalized aching. Formation 
of abscess is a rare complication. Most deaths due to brucellosis are caused by 
neurobrucellosis and endocarditis (Al-Dahouk and Nockler, 2014)  
 
In summary, many authors (Bashir et al., 1985; Al-Orainey et al., 1987; Rajapakse et 
al., 1987; Al-Kasab et al., 1988; Al-Aska 1989; Akhtar and Ali, 1989; Halim et al., 1993; 
and Al-Eissa 1999) reported fever with drenching sweats, loss of weight, nausea, 
vomiting, anorexia, lethargy, colitis, hepatosplenomegaly, spontaneous peritonitis, 
lymphadenopathy, sacroiliitis, ileitis, spondylitis, bursitis, osteomyelitis, mild anaemia, 
leukopenia, pancytopenia,  thrombocytopenia and gastro-intestinal complications are     
clinical symptoms of human brucellosis  
 
1.9 PROBLEM STATEMENT 
The population of livestock consumed in Lagos Nigeria is very high, which is more than 
40,000 ruminant animals per month excluding pigs and poultry. Nigeria has a large 
livestock population of about 104 million (FAOSTAT, 2010) which are mainly in the hand 
of nomadic farmers. These animals harbour Brucella species, and yet, investigation of 
brucellosis is not carried out routinely on these animals. As a result, this place the 
population of Lagos at risk of Brucella infection from livestock. Febrile illness and 
generalized aches and pains are major symptoms of human brucellosis. These similar 
signs are frequently observed in other diseases. Unfortunately, due to non-prioritization 
of brucellosis as a high public health issue by primary health care givers, brucellosis is 
hardly diagnosed in the health facilities despite the high-risk of exposure in the country. 
In addition, the nomadic farmers and the butchers who are involved in the handling of 
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potentially infected animals and their products on a daily basis have not been studied 
extensively to determine the extent of the problem. Therefore, there is paucity of data 
on the magnitude of the disease in terms of prevalence and incidence, which justifies 
the current study.  
 
1.9.1 Hypotheses 
(i) The prevalence of brucellosis is low among people at risk. 
(ii) The high febrile illness observed among people that visited hospitals for 
medical reasons are not due to brucellosis. 
(iii) Individuals, being in constant contact with animal products such as milk, 
meat and blood are likely not to be infected by Brucella organisms. 
(iv) Age and sex do not determine the prevalence of brucellosis in a given 
population.  
(v) Individuals at risk to brucellosis do not know about the disease. 
 
1.9.2 Aims and objectives of the study 
The aim of this study is to determine the sero-prevalence of brucellosis among people 
that are at risk in Lagos Nigeria. 
 
The specific objectives of the study are: 
 
i. To determine the sero-prevalence of brucellosis among veterinarians, 
slaughterers, butchers abattoir cleaners/blood packers, meat transporters and 
laboratory workers in some selected abattoirs and hospitals in Lagos Nigeria. 
ii. To determine the sero-prevalence of brucellosis among people with febrile 
diseases that visit some selected hospitals in Lagos Nigeria 
iii. To identify the risk factors that predisposes individuals to brucellosis in Lagos 
Nigeria. 
iv. To evaluate the sex and the age bracket of the populace with the highest 
sero-prevalence of the disease. 
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v. To determine the awareness level of brucellosis and treatment of the infection 
among individuals at risk in the selected abattoirs and hospitals. 
 
1.9.3  Significance of the study 
The study will help to ascertain the prevalence of human brucellosis among some 
randomly selected populace in Lagos Nigeria, so that the government and appropriate 
regulatory bodies for public and animal health can take necessary actions of prevention. 
 
 
 
 
 
 
 
 
 
  
36 
 
CHAPTER 2 
 
MATERIALS AND METHODS 
 
2.1  STUDY AREA 
The study location is Lagos State, the commercial capital of Nigeria, with a population of 
about 21 million people (Campbell, 2012). The city, with its adjoining conurbation, is the 
largest in Nigeria, as well as on the African continent (Lagos State Government, 2017).  
It is located in a coastal area, and is about 400m above sea level. It is at 6.45306 
[latitude in decimal degrees] and 3.39583 [longitude in decimal degrees]. Based on 
Köppen climate classification, the city experiences tropical savannah climate (Aw). The 
wet season is between April and October (with average annual rainfall of 1693mm); 
while the dry season is between November and March. The average temperature is 
270C. Geographically, Lagos State is classified into two, namely ‗Island and ‗Mainland‘.  
Administratively, Lagos consists of twenty local government areas and thirty-seven local 
council development areas. In addition, the whole state is divided into three 
constitutionally recognized senatorial districts. These senatorial districts are Lagos 
Central, Lagos East and Lagos West districts (City Newsline.com.ng, 2013).   
 
Furthermore, according to Healthcare Facilities Monitoring and Accreditation Agency 
(HEFAMAA), an agency of the government that is involved in the registration of health 
care facilities in the state, there are twenty-six government-owned general hospitals 
(about nineteen in Lagos metropolis), two hundred and fifty six primary health care 
centers, estimated one hundred and sixty trado-medical centres as well as two 
thousand eight hundred and eighty six accredited private 
hospitals/clinics/laboratories/ophthalmic/dental/diagnostic centers in Lagos State. In 
addition, there are two university-teaching hospitals in the state. People in need of 
treatment for various disease conditions including febrile illnesses visit these medical 
facilities. Also, many abattoirs are found in the city where thousands of livestock 
animals such as cattle, sheep, goat and pigs are slaughtered daily for public 
consumption. 
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Based on the senatorial districts/zoning of the state, the research was carried out in 
randomly picked representative hospitals and abattoirs in the three zones. These 
consist of four abattoirs and three secondary health care providers.  
 
 
Figure 2: Map of Lagos State, Nigeria (Source: Nigeria Galleria) 
 
 
 
Figure 3: Senatorial districts of Lagos State (Source: Umar Yussuf. https://umar-
yusuf.blogspot.com/2017/10/map-of-nigeria-senatorial-districts-by.html) 
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2.2  STUDY DESIGN 
It is a descriptive cross-sectional study involving some randomly selected populace at 
risk to brucellosis in Lagos Nigeria.  
 
2.3 STUDY POPULATION 
The study population include veterinarians, slaughterers, butchers, abattoir cleaners, 
blood packers, abattoir traders and service providers, laboratory workers, people with 
febrile illnesses and blood donors at the hospitals. The later three groups of participants 
were found in the hospitals while the initial strata of participants were abattoir-based 
respondents. 
 
2.4 SAMPLING AND SAMPLING SIZE DETERMINATION 
A mixed sampling method was used in population sampling of the abattoir workers while 
convenient sampling method was the approach at the health care centers. The mixed 
sampling method adopted at the abattoir involves stratified sampling method in which 
the respondents were picked from the different strata or groups present at the abattoir; 
and convenience sampling method for individuals that were easily accessible for 
participation in the research. The sample size was calculated using Raosoft online 
software for sample size calculations at 95% confidence interval with a marginal error of 
5%.  The prevalence rate of 24.1% was used in the calculation based on the research of 
Aworh et al. (2013).  
 
The target sample size was five hundred (n=500).  The breakdown of the sample size 
(and strata) is as follows:  butchers (n=78) out of an estimated total population of 45,000 
then slaughterers (n=53) out of an estimated population of 147; veterinarians (n=37) out 
of an estimated population of 62; cleaners (n=58) out of estimated population of 210; 
blood packers (n=69) out of estimated population of 595, laboratory workers (n=75) out 
of estimated populations of 1587; Eko meat van drivers (n=51) out of estimated 
populations of 125 and people with febrile illnesses (n=90).  However, because of the 
lack of cooperation and withdrawal of some individuals from the targeted study 
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populations, other unstated populace which were discovered at the abattoirs were 
included in the research. 
 
Sera samples were collected from three hundred and sixty two respondents (n=362) at 
the abattoirs. Sixty one (n=61) out of these were discarded because of the inability of 
the serum to separate from whole blood and heamolysis caused by improper 
storage/improper transportation from the site of bleeding to the laboratory where the 
serological tests were performed. Therefore, only three hundred and one (n=301) sera 
from abattoir were subjected to Rose Bengal Plate Test.  
 
The hospital-based participants were grouped as professionals, intermediate, manual 
skilled and unskilled respondents in terms of their levels of education and occupation. 
Classified under ―professionals‖ among the hospital-based respondents are 
accountants, doctors, risk managers, bankers and nutritionists among others; while 
customer care officers, secretaries, interior designers etc. are classified as intermediate 
workers. The manual-skilled workers include photographers, drivers and security 
officers. Roadside mechanics, barbers and farmers among the respondents are 
classified as unskilled workers (appendix J). 
 
Of the 149 hospital-based participants, only 121 were subjected to Rose Bengal Plate 
test, while the remaining ones (n= 28) were discarded due to unsuitability for use in the 
research i.e. blood sample were haemolysed. Sixty one (n=61) respondents out of 121 
patients were at the hospital for the treatment of febrile illnesses such as malaria, 
typhoid while the remainders (n=60) were blood donors for either their pregnant wives 
or as general blood donors. 
 
In all, five hundred and eleven respondents participated in the research; with three 
hundred and sixty two from the abattoirs and one hundred and forty nine from the 
hospitals. 
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2.5  ETHICAL APPROVAL 
Ethical approvals for the research were obtained from the Institutional Review Board, 
Nigerian Institute of Medical Research (NIMR), Yaba, Lagos Nigeria (appendix H); and 
Health Studies Higher Degree Committee of the College of Human Sciences, University 
of South Africa (REC-012714-039). The consent of the participants was sought before 
the commencement of the research. 
 
Approvals for the use of health and abattoir facilities were given by the Lagos Health 
Service Commission and Veterinary Division, Lagos State Ministry of Agriculture 
respectively (appendices D and F). However, the demand for another ethical scrutiny in 
one of the hospitals despite adequate approval by two ethical boards and the 
government also ‗slowed‘ down the pace of the study. One of the management staff of 
the hospital later resolved this. 
 
2.6  DATA COLLECTION 
2.6.1  Information session 
The Heads of the various groups of the people at risk were met and the purpose of the 
research/study was explained to them. These heads thereafter spoke to their respective 
team members to participate in the research. 
 
 
Figure 4: One of the information sessions at Oko-Oba abattoir and Lairage, Agege in Lagos, Nigeria 
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2.6.2  Questionnaire administration 
The respondents were invited to fill the questionnaire after signing the consent/assent 
form (appendix C & I). However, most of the people at the abattoir were illiterates.  
Hence, the content of the questionnaire was explained to them in two of the local 
languages, Hausa and Yoruba (with sometimes, the assistance of an interpreter) by the 
researcher while they provide the corresponding answer. The questions include socio-
demographic information, risk factors for brucellosis, clinical signs, awareness level and 
any treatment received for suspected symptoms (appendix B). 
 
2.6.3  Blood sample collection 
Qualified medical personnel using sterile syringe and needle (Medtrue enterprise co., 
China product) collected 5 ml of blood aseptically from the respondents (Figures 5 and 
6). The blood was then transferred into sterile bottles (without anti coagulants), which 
were kept in cool container with ice so as to keep it at a temperature of ~40C . The 
blood samples were then taken immediately to the immunology Laboratory at the 
Nigerian Institute of Medical Research, Yaba Lagos for the serological tests.  Sera were 
extracted immediately and tested for the presence of Brucella antibodies using Rose 
Bengal Plate Test antigen. The sera of sero-positive individuals to Rose Bengal Plate 
Test antigen were then stored at -200C until when they were processed on ELISA as a 
confirmatory test. The sera for the serological tests were extracted by allowing the effect 
of gravity in separating sera from whole blood and centrifuging at a rate of 10,000 rpm 
for 5 minutes. 
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Figure 5: Blood Sample Collection  
 
2.6.4  Serological Tests 
2.6.4.1  Rose Bengal plate test 
The Rose Bengal reagent used for the study contain Brucella abortus biovar 1 
(Weybridge 99 strain) inactivated by heat and phenol, coloured with Rose Bengal stain 
and diluted in an acidified buffer.  The reagent was obtained from ID.Vet Innovative 
Diagnostics, France. Equal volume (30 µl) of Rose Bengal antigen and serum where 
mixed, using a mixer on a white tile.  After 4 minutes under slight agitation, the presence 
of specific antibodies is demonstrated by the visible agglutinates. In the absence of 
specific antibodies, the mixture was homogenous.  
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Figure 6: Rose Bengal plate antigen test at the Nigerian institute of medical research, Lagos 
Nigeria 
 
Sera that reacted positively to Rose Bengal Plate antigen test were then subjected to 
ELISA test, which serves as confirmatory test.  
 
2.6.4.2  Indirect ELISA assay 
The ELISA test was carried out based on the manufacturer‘s (Vircell S.L, Spain) 
instruction. This can be accessed on (http://en.vircell.com/products/brucella-elisa/). The 
product insert is attached as appendix G. It was validated, with the positive, negative 
and cut off controls being run (appendix A). The antibody index was calculated from the 
optical density value obtained, using the formula: 
Antibody index= (sample O.D / cut off serum mean O.D.) x 10 
The calculated mean optical density (O.D) is 1.7485.  
 
The results interpretation corresponded to the table 4 below: 
Table 4: Indirect ELISA Assay result table 
Antibody Index Interpretation 
< 9  Negative 
9-11 Equivocal 
>11 Positive 
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Samples with equivocal results must be retested and/or a new sample obtained for 
confirmation; samples with indexes below 9 are considered negative meaning they did 
not contain IgG specific antibodies against Brucella; samples with indexes above 11 are 
considered positive, meaning IgG specific antibodies against Brucella are present. 
 
2.7  DATA MANAGEMENT AND ANALYSIS 
Descriptive statistics were used to summarize socio-demographic characteristics of the 
respondents while patterns of infection, distribution of the clinical signs of brucellosis 
and level/treatment of the disease among respondents were summarized with 
proportions and percentages. Bivariate analysis such as Chi-sqaure test was used to 
investigate the association between location of patients‘ and selected variables. All 
analysis was carried out using Statistical Packages for Social Sciences (SPSS) version 
20.0 at α0.05 significant level. 
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CHAPTER 3 
 
RESULTS 
 
3.1  SOCIO-DEMOGRAPHY OF RESPONDENTS 
Five hundred and eleven respondents (n=511) participated in the research study. 
However, data of only three hundred and twelve (n=312) abattoir-based respondents 
and one hundred and forty nine individuals (n=149) hospital participants were analysed. 
Of the aforementioned, sera of three hundred and one (n=301); and one hundred and 
twenty one (n=121) respectively were subjected to serological tests due to reasons 
explained in the previous chapter.  
 
The socio-demographic characteristics of the respondents (in alignment with objective iv 
of the study) are presented as follows: 
 
Table 5: Socio–demographic characteristics of abattoir respondents 
Variable Frequency Percentage 
Age of workers (years) 
  
<18 1 0.3 
18 – 24  13 4.2 
25 – 34  47 15.1 
35 – 44  139 44.6 
45 – 59  72 23.1 
>=60 22 7.1 
Nil 18 5.8 
Total 312 100 
Gender of workers 
 
 
Male 203 65.1 
Female 109 34.9 
Total 312 100 
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Occupation of workers 
Food vendor 13 4.2 
Trader 29 9.3 
Butcher  118 37.8 
Butcher (ponmo) 31 9.9 
Nurse 2 0.6 
Vets 21 6.7 
Cleaner 4 1.3 
Slaughterer 3 1 
Herdsmen 1 0.3 
De–boner  4 1.3 
Animal waste packer 1 0.3 
Administrative manager 2 0.6 
Slab manager 1 0.3 
Market coordinator 2 0.6 
Student 1 0.3 
Meat transporter 37 11.9 
Ticketer 1 0.3 
Tiler 1 0.3 
Herbal/Alcohol seller 2 0.6 
Abattoir contractor 1 0.3 
Task force 7 2.2 
Water seller 1 0.3 
Blood meal 1 0.3 
Carcass clearance 1 0.3 
Meat seller 7 2.2 
Civil servant 2 0.6 
Skin processor 3 1 
Others 12 3.8 
Nil 3 1 
Total 312 100 
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Table 6: Socio–demographic characteristics of hospital-based people at risk to brucellosis 
Variable Frequency Percentage 
Age of respondents (years) 
  
<18 3 2 
18 – 24  19 12.8 
25 – 34  60 40.3 
35 – 44  34 22.8 
45 – 59  14 9.4 
>=60 14 9.4 
Nil 5 3.4 
Total 149 100 
Gender of respondents 
 
 
Male 96 64.4 
Female 52 34.9 
Nil 1 0.7 
Total 149 100 
Occupation of respondents 
  
Professional 25 16.8 
Intermediate 16 10.7 
Manual skilled 12 8.1 
Unskilled 96 64.4 
Total  149 100 
Location of respondents 
  
Lagos General Hosp, Odan 48 32.2 
Isolo General Hosp, Lagos 53 35.6 
Ikorodu General Hosp, Lagos 48 32.2 
Total 149 100 
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3.2  GROUPS OF RESEARCH PARTICIPANTS AND THEIR POPULATIONS 
The various groups of individuals from which blood were collected are summarized in 
table 7 and 8 below. This aligns with objectives i and ii of the research study. 
 
Table 7: The various groups of participants at the abattoir 
People at Risk to Brucellosis 
Number of Individuals per 
group 
Main Butchers 167 
Ponmo ‗butchers‘ (process skin to ponmo, a widely consume ‗skin 
product‘ in Nigeria) 
35 
Specialized Slaughterers 3 
De-Boning Individuals 3 
Veterinarians 31 
Animal Sellers/Dealers 8 
Blood Meal Makers/Packers 1 
Eko Meat Van Drivers/Meat Transporters/Manual Meat Transporter 
(Alabo are three) 
38 
Cow Horn Dealers 3 
Animal Carcass Disposer 1 
Food Vendors/traders 37 
Abattoir Managers/Taskforce Members/Slab Manager/Clerical 
officer/Ticketer etc. (Ensures orderliness in the abattoir) 
15 
Local Herbal drug seller 2 
Lotto Coordinator 1 
Vets office Assistant 1 
Abattoir Engineering Staff 1 
Stationery Printer 1 
Cleaners/ingesta packers 4 
Gall Stone Merchants 2 
Tiller 1 
Herdsmen  1 
Nurse  2 
Students  1 
Not stated 3 
Total number of individuals sampled 362 
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Table 8: Category of participants according to occupations at the hospital (appendix J) 
Occupation of Respondents Number of Participants 
Professionals  25 
Intermediate 16 
Manual skilled  12 
Unskilled 96 
Total  149 
 
3.3  RESULTS OF ROSE BENGAL PLATE TEST 
Sera from three hundred and one (n=301) abattoir-based individuals and one hundred 
and twenty one (n=121) hospital-based respondents were subjected to Rose Bengal 
Plate antigen test (RBPT).  Twenty seven people (8.97%) were sero-positive to the 
infection. A bar chart showing the occupations of the sero-positive respondents is 
presented below: 
 
 
Figure 7: Bar Chart showing the Occupations of the Sero-Positive Individuals on RBPT 
 
From the chart above, 55.6 % (n=15) of the sero-positive respondents were butchers; 
14.8% (n=4) were veterinarians, 7.4% each (n=2) were meat transporters and cow 
bone/horn dealers while the remaining respondent groups were 3.7% each. Of the 
twenty seven individuals, 66.7% (n=18) were males while the remaining 33.3% (n=9) 
were females. This is shown in the bar chart below: 
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Figure 8: Gender of sero-positive individuals on RBPT 
 
3.4  RESULTS OF INDIRECT ELISA TEST 
Sera from the twenty-seven sero-positive individuals to brucellosis on Rose Bengal 
plate antigen were subjected to Brucella indirect ELISA assay as a confirmatory test. 
Three (n=3) were confirmed by the assay, while one was equivocal.  This means that 
11.1% were confirmed positive by the ELISA test (Appendices E & K). 
 
Table 9: Results of the ELISA Test 
Results Frequency % (n) 
Sero-positives  11.1 (3) 
Equivocal 3.7 (1) 
Sero-negatives  85.2 (23) 
 
3.5 DISTRIBUTION OF BRUCELLOSIS-RELATED CLINICAL SIGNS AMONG 
THE RESPONDENTS 
Some clinical signs associated with brucellosis were observed among some of the 
respondents. These clinical signs include fever, orchitis, abortion, joint pain, lower 
backache, regular headache and weakness. The distributions of the clinical signs are 
shown in Tables 10 and 11 
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Table 10: Distribution of clinical signs associated with people at risk to brucellosis at the abattoirs 
Variable Frequency Percentage 
Fever 
  
Yes 109 34.9 
No 201 64.4 
Nil 2 0.6 
Total 312 100 
Joint pain 
 
 
Yes 184 59 
No 126 40.4 
Nil 2 0.6 
Total  312 100 
Lower backache 
 
 
Yes 197 63.1 
No 113 36.2 
Nil 2 0.6 
Total  312 100 
Regular headache 
 
 
Yes 130 41.7 
No 180 57.7 
Nil 2 0.6 
Total  312 100 
Weakness 
  
Yes 111 35.6 
No 198 63.5 
Nil 3 1 
Total  312 100 
Orchitis 
 
 
Yes 20 6.4 
No 196 62.8 
Nil 96 30.8 
Total  312 100 
Miscarriage 
  
Yes 57 18.3 
No 249 79.8 
Nil 6 1.9 
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Total  312 100 
   
Nil means ‗not stated‘. 
 
Table 11: Distribution of clinical signs associated with hospital-based respondents 
Variable Frequency Percentage 
Fever 
  
Yes 17 11.4 
No 130 87.2 
Nil 2 1.3 
Total 149 100 
Joint pain 
 
 
Yes 27 18.1 
No 114 76.5 
Nil 8 5.4 
Total  149 100 
Lower backache 
 
 
Yes 27 18.1 
No 114 76.5 
Nil 8 5.4 
Total  149 100 
Regular headache 
 
 
Yes 25 16.8 
No 116 77.9 
Nil 8 5.4 
Total  149 100 
Weakness 
 
 
Yes 40 26.8 
No 101 67.8 
Nil 8 5.4 
Total  149 100 
Orchitis 
 
 
Yes 11 7.4 
No 85 57 
Nil 53 35.6 
Total  149 100 
Miscarriage 
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Yes 9 6 
No 126 84.6 
Nil 14 9.4 
Total  149 100 
Nil means ‗not stated‘ 
 
Table 12: Distribution of clinical signs associated with sero-positive individuals at the abattoirs 
Variable Frequency Percentage 
Fever 
  
Yes 11 40.7 
No 16 59.2 
Nil 0 0 
Total 27 100 
Joint pain 
 
 
Yes 18 66.7 
No 9 33.3 
Nil 0 0 
Total  27 100 
Lower backache 
 
 
Yes 17 63.0 
No 10 37.0 
Nil 0 0 
Total  27 100 
Regular headache 
 
 
Yes 11 40.7 
No 16 59.3 
Nil 0 0 
Total  27 100 
Weakness 
  
Yes 13 48.2 
No 14 51.8 
Nil 0 0 
Total  27 100 
Orchitis 
 
 
Yes 0 0 
No 18 66.7 
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NA 9 33.3 
Total  27 100 
Miscarriage 
  
Yes 08 29.6 
No 19 70.4 
Nil 0 0 
Total  27 100 
 
NA-Not applicable 
 
3.6 RISK FACTORS FOR BRUCELLOSIS 
The analyses of the risk factors that pre-dispose individuals to brucellosis are presented 
in tables 13 and 14 below, in alignment with objective iii of this study: 
Table 13: Distribution of possible source of Brucella infection to abattoir respondents 
Variable Frequency Percentage 
Location of workers 
  
Itire slaughter slab 63 20.2 
Kwil abattoir 29 9.3 
Ikorodu slaughter slab 46 14.7 
Oko-oba Agege  abattoir 174 55.8 
Total 312 100 
Fura (unpasteurized milk) 
consumption  
 
Yes 189 60.6 
No 120 38.5 
Nil 3 1 
Total 312 100 
Wara (fresh cheese) 
consumption   
Yes 176 56.4 
No 133 42.6 
Nil 3 1 
Total 312 100 
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Ponmo (animal skin) 
consumption  
 
Yes 285 91.3 
No 24 7.7 
Nil 3 1 
Total  312 100 
Meat 
 
 
Yes 298 95.5 
No 12 3.8 
Nil 2 0.6 
Total  312 100 
Suya (spicy skewered 
beef) consumption   
Yes 216 69.2 
No 96 30.8 
Total  312 100 
Animal rearing 
 
 
Yes 89 28.5 
No 223 71.5 
Total  312 100 
Nil means ‗not stated‘ 
 
Table 14: Distribution of possible source of Brucella infection to hospital-based respondents 
Variable Frequency Percentage 
Fura (unpasteurized 
Milk) consumption   
Yes 103 69.1 
No 41 27.5 
Nil 5  
Total 149 100 
Wara (Fresh Cheese) 
consumption  
 
Yes 21 14.1 
No 123 82.6 
Nil 5  
Total  149 100 
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Ponmo (Animal skin) 
consumption   
Yes 75 50.3 
No 69 46.3 
Nil 5 3.4 
Total  149 100 
   
Meat 
 
 
Yes 106 71.1 
No 38 25.5 
Nil 5 3.4 
Total  149 100 
Suya (spicy skewered 
beef) consumption   
Yes 97 65.1 
No 51 34.2 
Nil 1 0.7 
Total  149 100 
Animal rearing 
 
 
Yes 25 16.8 
No 122 81.9 
Nil 2 1.3 
Total  149 100 
Nil means ‗not stated‘ 
 
 
Table 15: Distribution of brucellosis awareness level and treatment against brucellosis among 
people at risk at the abattoirs 
Variable Frequency Percentage 
Brucellosis awareness     
Yes 55 17.6 
No 255 81.7 
Nil 2 0.6 
Total  312 100 
Brucellosis treatment 
  
Yes 2 0.6 
No 308 98.7 
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Nil 2 0.6 
Total  312 100 
Nil means ‗not stated‘ 
 
Table 16: Distribution of brucellosis awareness level and treatment against brucellosis among 
hospital based patients 
Variable Frequency Percentage 
Brucellosis 
awareness  
 
Yes 17 11.4 
No 129 86.6 
Nil 3 2 
Total  149 100 
Brucellosis treatment 
  
No 143 96 
Nil 6 4 
Total  149 100 
Nil means ‗not stated‘ 
 
 
Table 17: Results of bivariate analysis of Infectious status and gender at the abattoirs 
Variable Gender χ2 P-value 
Male Female 
Infection status 
(unpasteurized milk) 
Positive 
Negative 
Total 
 
 
162 (79.8) 
41 (20.2) 
203 (100.0) 
 
 
27 (55.9) 
79 (44.1) 
106 (100.0) 
4.763 0.027** 
Infection status 
(fresh cheese) 
Positive 
Negative 
Total  
 
 
137 (67.5) 
66 (32.5) 
203 (100.0) 
 
 
39 (35.8) 
67 (64.2) 
106 (100.0)  
4.638 0.031** 
** significant p-value 
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Table 17 showed the test association between infection status and selected variables at 
the abattoir. There were significant associations between unpasteurized milk (p=0.027) 
and fresh cheese (p=0.031) and gender.at abattoir. 
 
Table 18: Results of bivariate analysis of infectious status and gender at General Hospital 
Variable Gender χ2 P-value 
Male Female 
Infection status 
(unpasteurized Milk) 
Positive 
Negative 
Total 
 
 
63 (65.6) 
33 (34.4) 
96 (100.0) 
 
 
41 (85.4) 
7 (14.6) 
48 (100.0) 
2.136 0.105 
Infection status 
(fresh cheese) 
Positive 
Negative 
Total  
 
 
13 (13.5) 
83 (86.5) 
96 (100.0) 
 
 
8 (16.7) 
40 (83.3) 
48 (100.0) 
2.774 0.093 
** significant p-value 
 
Table 18 showed the test association between infection status and selected variables at 
the abattoir. There were no significant associations between unpasteurized milk 
(p=0.105) and fresh cheese (p=0.093) and gender at the General Hospitals 
 
Table 19: Bivariate analysis association of suggestive symptoms of brucellosis with location of 
the participants 
Variable 
Location 
χ2 P–value  
Abattoir General Hospital 
Fever  
  
27.803 P<0.001** 
Yes 109(86.5) 17(13.5) 
No 201(60.7) 130(39.3) 
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Total 310(67.8) 147(32.2) 
Joint pain 
  
62.928 P<0.001**  
Yes 184(87.2) 27(12.8) 
No 126(52.5) 114(47.5) 
Total 310(68.7) 141(31.3) 
Lower back 
ache   
76.426 P<0.001**  
Yes 197(87.9) 27(12.1) 
No 113(49.8) 114(50.2) 
Total 310(68.7) 141(31.3) 
Regular 
headache   
25.174 P<0.001**  
Yes 
130(83.9) 
25(16.1) 
No 180(60.8) 116(39.2) 
Total  310(68.7) 141(31.3) 
Weakness 
  
2.478 0.115 
Yes  111(73.5) 40(26.5) 
No 198(66.2) 101(33.8) 
Total 309(68.7) 141(31.3) 
Orchitis 
 
 
0.359 0.549 
Yes 20(64.5) 11(35.5) 
No 196(69.8) 85(30.2) 
Total 216(69.2) 96(30.8) 
Miscarriage 
 
 10.53 0.001** 
Yes 57(86.4) 9(13.6) 
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No 249(66.4) 126(33.6) 
Total 306(69.4) 135(30.6) 
 
 
Table 20: Bivariate analysis of risk factors with brucellosis status of the participants 
Variable 
Brucellosis Status 
χ2 P–value  
Positive Negative 
Age of participants 
(years)   
7.235 0.204 
<18 0(0.0) 1(100.0) 
18 – 24  0(0.0) 13(100.0) 
25 – 34  5(10.6) 42(89.4) 
35 – 44  11(7.9) 128(92.1) 
45 – 59  11(15.3) 61(84.7) 
>=60 0(0.0) 22(100.0) 
Total  27(9.2) 265 (90.8) 
Gender of 
participants   
0.033 0.855 Male 18(8.9) 185(91.1) 
Female 9(7.3) 101(92.7) 
Total 27(8.7) 285(91.3) 
Occupation of 
participants   
4.994 0.172 
Professional  3(12.0) 22(88.0) 
Intermediate 3(25.0) 9(75.0) 
Manual skilled 0(0.0) 3(100.0) 
Unskilled 21(7.7) 251(92.3) 
Total 27(8.7) 285(91.3) 
Fura 
(Unpasteurized 
Milk) consumption 
  
7.186 0.007**  Yes 
 
 
No 23(12.2) 166(87.8) 
 
Total  
4(3.3) 116(96.7) 
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 27(8.7)  282(91.3)  
Wara (Fresh 
Cheese) 
consumption 
  
5.231 0.022** Yes 
 
 
No 21(11.9) 155(88.1) 
Total 6(4.5) 127(95.5) 
 27(8.7) 282(91.3) 
Ponmo (Animal 
skin) consumption   
0.682 0.409 
Yes 
  
No 26(9.1) 259(90.9) 
Total 1(4.2) 23(95.8) 
 27(8.7) 282(91.3) 
Animal rearing 
  
0.576 0.448 
Yes 6(6.7) 83(93.3) 
No 21(9.4) 202(91.6) 
Total 27(8.7) 285(91.6) 
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CHAPTER 4 
DISCUSSION 
 
The results of the research revealed that brucellosis is mainly related to occupational 
disease (objectives i & ii). Twenty-seven (n=27) sero-positive individuals were from the 
abattoirs; and none found at the hospitals. This finding correlates with findings of many 
research works on human brucellosis (Mukhtar, 2008, CDC, 2015; WHO 2018).  On 
Rose Bengal test, the ―butchers‖ category showed the highest number of sero-positive 
individuals (15 out of 27 or 55.6% of the total Brucella-seropositive persons). This result 
was in agreement with the research work of Aworh et al. (2013) at Abuja, Nigeria; 
Cadmus et al. (2006) at Ibadan Nigeria;  Swai & Schoonman (2009) at Tanzania; El 
Kholy et al. (2009) at Egypt; and Amegashie et al. (2017) at Ghana.  The second 
highest sero-positive group of people to brucellosis was ―the veterinarians‖, accounting 
for 14.8% of the twenty-seven positives. This result contradicts the earlier research 
report of Awad, (1998) and Aworh et al. (2013) in which the veterinarians were not sero-
positive to the infection, attributed to their short exposure to animals during meat 
inspection, use of personal protective equipment as well as their knowledge of the 
zoonotic disease. However, Patil et al. (2013) and Sambrani et al. (2016) reported 
incidence of brucellosis among veterinarians in their research work. The infection of the 
veterinarians in this study might probably be as a result of inadequate protection of the 
veterinarians which may be sequel to non-provision of protective materials by the 
government 
 
Furthermore, two meat transporters were both sero-positive to RBPT and ELISA tests. 
These transporters move meat within the abattoir using cart and motorcycle. The level 
of exposure of these men to raw meat could be responsible for their infection by the 
bacteria. The other group of meat transporters, Eko Meat Van drivers were not sero-
positive to the infection. The later group of meat transporters move meat from the 
abattoir to different part of the state in enclosed vans, with level of exposure to physical 
contacts with meat relatively minimal when compared with the other group of meat 
transporter. 
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Moreover, one of the sero-positive respondents who deals with cow bones confirm the 
possibility of the transmission of Brucella organisms through bones as found in the 
reports of Scian et al. (2012) and Giambartolomei et al. (2017).  Another sero-positive 
respondent was a cow horn dealer. The mechanism of infection through animal horn 
has not been reported but the man might have been infected through the horns placed 
in contaminated slurry and soils of the abattoir. 
 
The fact that one of the sero-positive individuals is a trader who sells water to the 
abattoir workers means that non-occupational people who visits the abattoir to buy meat 
or for any other purpose and those who live in houses very close to the abattoir are also 
at risk to contracting the infection.   
 
In addition, it must be noted that no sero-positive individuals were found at two (Ikorodu 
Slaughter Slab and Kwil Abattoir and Farms) out of the four abattoirs visited in the 
research. Slaughtering and other animal-related activities in these two abattoirs are 
neater and better carried out when compared with the other two abattoirs. This shows 
that level of cleanliness and proper waste disposal in an abattoir has influences on 
transmission of Brucella pathogen from animals to humans as was observed in the 
report of Corbel (2006); WHO (2006) and Wang et al. (2015).  They reported that 
Brucella could survive in dust, manure, water, manure slurry, aborted fetuses, soil, meat 
and dairy products for considerable periods, and human/animal infections originate from 
direct or indirect contact with infected animals or Brucella-contaminated environments. 
However, before the conclusion of this study, the Lagos State Government was already 
carrying out some reforms at the biggest abattoir in the state (Oko Oba Abattoir & 
Lairage, Agege), where majority of the sero-positive respondents were found. 
 
 
The level of brucellosis awareness and treatment for brucellosis among the respondents 
are also very low (tables 15 and 16). Considering the chronic course of brucellosis as 
well as its consequences, awareness campaigns should be conducted to inform people 
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at risk in an endemic region like Nigeria (objective v). Currently, there is no regulation 
for implementation of an effective control programme of the disease.  In addition, 
significant attention for the treatment of possible brucellosis infection among the 
populace is not catered for. This perception is based on the few respondents who 
turned to traditional medicine for brucellosis treatment. 
 
The clinical signs suggestive of human brucellosis in this study were fever, joint pain, 
lower backache, regular headache and miscarriage. However, orchitis does not have a 
significant association with the location. The prevalence rate of 6.4% and 7.4% among 
the abattoir-based respondents and hospital-based respondents respectively is still a 
source of concern (table 19). 
 
The main risk factors significant for human brucellosis according to this research and as 
shown in table 20 are consumption of fura (unpasteurized milk) and wara (fresh 
cheese). This is in agreement with many research reports worldwide which states that 
milk and milk products consumption are a major source of human brucellosis 
(Giannakopoulos et al., 2006; Mensah et al., 2011; Guoqiu et al., 2013; Khazaei et al., 
2016; Wafa, 2017). 
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CHAPTER 5 
 
SUMMARY AND CONCLUSION 
 
Brucellosis is present in Lagos State Nigeria. The prevalence rate of 8.97% is a 
significant infection rate, considering the possibility of higher infection rate due to the 
operation of illegal abattoirs, slaughter slabs and lack of regulated control measures in 
the state. In addition, the fact that none of the hospital respondents is sero-positive to 
brucellosis further shows people that are not working/trading in places where animals 
are slaughtered are not at much risk to brucellosis as people that work/trade in 
slaughter houses. However, consumption of unpasteurized milk/milk products 
predisposes all the populace irrespective of the place of occupation to Brucella infection 
as reported by El-Koumi et al. (2013).  
In term of gender, males are the dominant gender in the abattoir based 
occupation/trading, with females accounting for just 34.9% (out of 312 respondents) of 
the abattoir based respondents. The number of sero-positive males to females is in ratio 
2:1. However, the number of females found at the various abattoir shows that there is 
increasing feminine participation in abattoir activities. There is therefore the need for 
increased brucellosis awareness among the populace since high feminine brucellosis 
infection may lead to a decline in the population over time. For the hospital-based 
respondents, the percentage of women that participated is surprisingly 34.9% (out of 
149 participants) too. This shows that women in Lagos make effort in knowing their 
health status; therefore, educating a woman is educating a nation.  
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Individuals in age bracket 35-44 are mostly involved in abattoir work and trading, 
according to the result of this research. 44.4% of the sero-positive individuals fall in this 
age group, being the highest among them. However, age is not significant in relation to 
brucellosis infection. Also, brucellosis awareness level and treatment is very low among 
the respondents.  
The prevalence rate of orchitis among abattoir-based respondents (6.4%) and hospital-
based (7.4%) in this study is a source of concern. Hence, effort should be made to find 
out the cause of this inflammation in the state. 
In the light of all the aforementioned, I hereby recommend that there should be 
increased surveillance of brucellosis in collaboration with the surrounding states/country 
(Ogun State Nigeria and Republic of Benin). Also, there is a need for the government to 
employ more veterinarians so as to improve meat inspection service in the state. In 
addition, there should be massive public enlightenment on brucellosis infection. Lastly, 
units for One Health (which comprises the medical and veterinary personnel) should be 
established by the government/relevant stakeholders so as to enhance control and 
treatment of brucellosis and other zoonotic infection. 
5.1  LIMITATIONS OF THE STUDY 
The challenges encountered in the course of the research were enormous. These 
challenges include: 
 
(i) Unwillingness of many of the people at risk especially in the abattoir to participate in 
the research. Time and funds were wasted in trying to convince the people to 
participate in the research. Hence, the populations of the target abattoir-based 
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professionals were altered in order to encourage participation of more individuals in 
the research. 
 
(ii) The progressive, rapid decline of Nigerian Naira in comparison to other major 
currencies (about 300% increase in exchange rate) between the time the research 
budget was made  and when the research was carried out made the antigens, kits 
and logistics to be extremely expensive. This major constraint retarded the progress 
of the research. 
 
5.2 FUTURE PERSPECTIVE 
The possibility of Brucella pinnipedialis and Brucella ceti infection may be high in the 
state because Lagos is a coastal city, with many of the residents being exposed to the 
coastal water regularly. Hence, research work on prevalence rate of the above-
mentioned pathogens should be carried out.  
 
If possible, isolation and identification of Brucella spp. should be conducted in those 
areas where serological positive individuals have been identified. 
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Appendix B: Questionnaire used during survey 
 
Survey of brucellosis among people at risk in Lagos, Nigeria 
(An MSc Research project of a student of University of South Africa) 
(a) Title: (Prof/Mr. /Mrs. /Miss/Dr.)………………   (b) Gender: ……………. (c) Age:  
(d)Address:………………………………………………………………………….…………… 
(e) Occupation: ………………………………  
(f) Which of these do you consume? Milk  Cheese Cow skin  Meat     (You 
can tick as many as you consume raw) 
(g) Do you eat suya (spicy skewered meat) Yes No . If yes, how many times per 
month? ……………………………………………….. 
(h) Do you keep/rear animals ……………If yes, which animals? 
……………………………. 
(i) Did any of your animals mentioned in (h) above experience stillbirth or abortion?  
Yes   No  I don‘t know   
If yes, which one ………………………………… 
(j) Do you experience fever every day?   Yes           No  
(k) Which of these symptoms have you been experiencing for several weeks? 
Joint pain  lower backache  regular headache  weakness orchitis none  
 (You can tick more than one item) 
(l) Did you experience miscarriage more than twice Yes   No   . If yes, how many 
times?  ………………………………………… 
(m) Have you heard of the disease called brucellosis? Yes  No   
(n) Have you been treated for brucellosis before? Yes   No    If yes, which 
drug(s) were administered to you ……………………………………… 
Thanks for participating in this research. Your information will be kept confidential. 
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Appendix C: Consent form 
 
CONSENT FORM 
Project Title: Survey of brucellosis among people at risk in Lagos, Nigeria 
Principal investigator: Akinroyeje Kehinde Adeyemi (MSc Student, University of 
South Africa) 
 
I am conducting a survey in order to establish if people have been exposed to a 
possible brucellosis infection (a disease that can affect people that work with animal 
farms, abattoirs and those that handle animals and their products) in Lagos Nigeria.  If 
you are willing to be part of this study, I will be grateful if you allow the medical 
personnel to collect blood samples that will be tested in the laboratory to check for this 
disease.  You will also fill a questionnaire that will provide us with the information that 
will assist us during the information sessions and our feedback to you at the end of this 
research work.  Collection of the blood and filling of the questionnaire will take not more 
than an hour of your time. 
 
The medical personnel will collect about 5 ml of blood.  You may feel a little discomfort 
when the syringe needle is used but that feeling will disappear immediately.  A new 
syringe will be used for each individual. 
 
This research will be of great benefit to you and the country at large.  It will help you 
know more about brucellosis, which is a disease that causes fever and also affects the 
reproductive system.  This disease is preventable and treatable.  If you know your 
status, you will be able to observe the relevant precautions. 
 
I promise to keep all the information from the questionnaire as well as the result of your 
blood test confidential.  However, if the government want to re-use the data generated 
from this research, it will be able to access them. 
 
Participation in this research is voluntary, you can withdraw at anytime and you will not 
be penalized.  If you are a minor, consent from your parents will be required. 
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If you have decided to participate in this study, please write your name and append your 
signature 
I ……………………………………want to be part of this research study. 
………………………………    ………………………………… 
Signature                 Date 
 
If you have any question concerning this study, you may contact Dr. Adesina Adeiga at 
Nigerian Institute of Medical Research (NIMR), Yaba, and Lagos Nigeria. Tel: 
08023026544 or 08097631483; email: aadeiga@yahoo.com. You may also contact Dr. 
Prudence Kayoka-Kabongo at UNISA on Telephone no +27827750754; 
email:kabonpnk@unisa.ac.za. 
If you have any question about your right or if there is any adverse consequence as a 
result of your participation in this study, please contact the Chairman, Institutional 
Review Board (IRB), Nigerian Institute of Medical Research, Yaba Lagos Nigeria or 
Chair of Department, Department of Agriculture and Animal Health, University of South 
Africa, South Africa. 
 
WITNESSES 
1. ....................................................... 2.…………………………………. 
 
Signature and date 
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Appendix D: Approval letter from the Lagos State Health Service Commission 
 
 
 
 
104 
 
 
Appendix E: print out of ELISA result sheet 
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Appendix F:  Approval letter from the Veterinary Division, Lagos State Ministry of Agriculture 
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Appendix G:  Package insert from the manufacturer for the ELISA Kit 
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Appendix H 
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Appendix I 
ASSENT FORM 
Project Title: Survey of Brucellosis Among People at Risk in Lagos Nigeria 
Principal Researcher: Akinroyeje Kehinde Adeyemi (MSc Student, University of South 
Africa) 
I am doing a research in order to know the number of people that have brucellosis infection (a 
disease that is common among people that work in animal farms, abattoirs and those that 
handle animals) in Lagos Nigeria. If you want to be part of this study, I want you to allow the 
medical personnel to collect blood samples from your body so as to carry out blood test in order 
to know if you have the disease. You will also fill a questionnaire as I want to know about things 
you do that can make you to be infected with the disease pathogen. You can do all these within 
an hour. 
The medical personnel will collect about 5 ml of blood from your body. Hence, you may feel a 
little discomfort when the syringe needle is used on your body. However, I will make sure that 
the discomfort will be minimal. Also because of your likely fear of disease transmission to your 
body, I will ensure that only new syringe needle is used on your body. 
This research will be of great benefit to you if you participate. It will help you know if you have 
brucellosis, which is a disease that makes somebody to have undulating fever and also affects 
the reproductive system. If you know your status about the disease, you can then go to the 
hospital where you will be treated. 
I promise to keep all the information you fill in the questionnaire as well as the result of your 
blood test confidential. However, if the government/government agencies want to re-use the 
data that will be gotten from this research, I will give it to them. 
Participation in this research is voluntary, and you can withdraw at anytime. You will not be 
penalized if you do not want to participate in the study or if you decide to withdraw at anytime. 
Your parents will know about this study also. 
If you decide you want to be in this study, please write your name and append your signature 
I ………………………………………………………………. want to be part of this research study. 
………………………………    ………………………………… 
Signature      Date 
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If you have any question concerning this study, you may contact Dr. Adeshina Adeiga at 
Nigerian Institute of Medical Research (NIMR), Yaba, Lagos Nigeria. Tel: 08023026544 or 
08097631483; email: aadeiga@yahoo.com. You may also contact Dr. Prudence Kayoka-
Kabongo at UNISA on Telephone no +27827750754; email:kabonpnk@unisa.ac.za 
If you have any question about your right or if there is any adverse consequence as a result of 
your participation in this study, please contact the Chairman, Institutional Review Board (IRB), 
Nigerian Institute of Medical Research, Yaba Lagos Nigeria or Chair of Department, Department 
of Agriculture and Animal Health, University of South Africa, South Africa. 
 
WITNESSES 
1. ............................................................................................ 
 
2. ........................................................................................... 
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Appendix J 
 
Specific jobs of hospital-based respondents 
Professionals Intermediate Manual skilled Unskilled  
Teacher  students hairdresser Trader  
Doctor Customer care 
officer 
Electrician  transporter 
Accountant  Secretary  barber Pastor  
Nutritionist  Entrepreneur  caterer attendants 
Banker  Merchandizer  Mechanic  Business women 
Marine dealer  Interior Designer Artisan  Farmer  
Civil servant  Movie producer Fashion designer  Self employed  
Travels & Tour 
consultants 
 Welder  Toll collector 
Electrical engineer  Bricklayer   
Risk Manager   Photographer   
Nurse     
Credit support 
manager  
   
Academics    
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Appendix K 
Results of ELISA IgG test for sero-positive individuals on RBPT for brucellosis  
 
 
Name Sample Optical Density 
Sample O.D/1.7485 (Mean O.D)= Antibody 
Index 
1 0.08 0.46 
2 0.22 1.26 
3 0.751 4.3 
4 0.104 0.6 
5 0.153 0.88 
6 0.048 0.28 
7 0.158 0.9 
8 0.04 0.23 
9 0.392 2.24 
10 0.077 0.44 
11 0.134 0.77 
12 0.088 0.5 
13 0.239 1.37 
14 0.119 0.68 
15 0.122 0.7 
16 0.069 0.4 
17 0.114 0.65 
18 0.132 0.76 
19 0.205 1.17 
20 0.233 1.33 
21 0.139 0.8 
22 0.121 0.69 
23 1.946 11.13 
24 2.486 14.22 
25 2.482 14.2 
26 0.12 0.69 
27 1.611 9.21 
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NB: ELISA antibody index value of 11 and above means the individual is sero-positive 
to brucellosis; between 9-11 is equivocal while value less than 9 is negative. 
 
 
 
